SUDA Receives $0.7m R&D Tax Incentive Refund

5th February 2016, ASX Announcement

SUDA Ltd (AX: SUD), a leader in oro-mucosal drug delivery, today announces that it has received a refund of $0.7 million from the Australian Taxation Office under the the R&D Tax Incentive for eligible expenditure during the 2015 financial year.

The R&D tax incentive provide a tax offset for eligible R&D activities and targets R&D benefiting Australia. The incentive, which came into effect in 2011 and replaces the R&D tax concession, encourages companies to engage in R&D.

Commenting on the refund, Mr Stephen Carter, Cheif Executive Officer of SUDA said:

“The R&D Tax Incentive is a valuable benefit for companies such as SUDA, which are investing to develop innovative new therapies. The refund strengthens our cash position as we continue to negotiate with prospective partners and advance our pipeline.

To read the full announcement, please click here.  

Folkestone to Hold Investor Teleconference

5th February 2016, ASX Announcement

Folkestone Investment Management Limited as Responsible Entity of the Folkestone Education Trust (“FET” or the “Trust”) will be announcing its financial results for the half year ended 31 December 2015 on Tuesday 16 February 2016.

After release of the results, the Trust intends holding an investor teleconference on Tuesday 16 February 2016. Management invites investors to participate in this teleconference in which the Trust’s HY16 results and presentation will be discussed. There will be an opportunity for participants to ask questions at the end of the teleconference.

To register for the teleconference please follow the registration details below.

Meeting:  Folkestone Education Trust HY16 Results to 31 December 2015
Date:  Tuesday 16 February 2016
Start time:  2:30 PM AEDT
Duration:  30 minutes plus questions
Register attendance:  To register please click here You must register by 12 noon on the 16 February 2016 to participate

Once you have registered, you will be provided with the information you need to join the conference, including dial-in numbers and a unique passcode.

If you need assistance while on the teleconference, press *0 on your telephone, and an operator will be happy to assist you.

To read the full announcement, please click here.

Warren Ebert’s Sentinel Property Wants Unity Pacific for ASX Listing

4th February 2016, By Ben Wilmot, The Australian

Warren Ebert’s Sentinel Property Group will push on with its ­attempt to list on the Australian Securities Exchange via a takeover of the property funds group Unity Pacific.

Sentinel, which has snapped up shopping centres, office towers and warehouses around the country for its unlisted trusts that have grown to about $1 billion, wants to list as a property fund manager. Unity Pacific said late on Tuesday that it would seek expressions of interest in its ­corporate vehicle and remaining assets, once the property known as 308 Queen Street/88 Creek Street, Brisbane, is sold.

In December, Sentinel made an offer to fund a buyback of all the UPG securities it did not own and built up its stake in the company to 5.01 per cent.

Sentinel yesterday reconfirmed its interest in UPG and advised that “it will be actively seeking to participate in this process”. Sentinel’s offer was pitched at UPG’s net asset backing and it entered into a short period of ­exclusive talks but these ended at the end of January.

 To read the full article, please click here

 

DomaCom Moves to Conducting IPO After Raising $8m

KEY HIGHLIGHTS:

  • Total of $8m raised from sophisticated and professional investors
  • Pre-IPO share price was $0.50
  • DomaCom now has over 160 shareholders
  • IPO planned for Q3 2016

DomaCom Limited, owner of Australia’s first regulated fractional property investment fund, has raised $8 million, laying the foundations for a planned public listing in the third quarter of this year.

Sophisticated and professional investors have supported the $0.50 a share capital raising, with DomaCom’s share register now boasting more than 190 shareholders.

DomaCom CEO and founder Arthur Naoumidis says: “This capital raising is an exciting step towards a planned public listing in the third quarter of the year.

It’s been a long journey since DomaCom first introduced the concept of fractional property investing to the market in 2012 but we are now starting to gather some real traction in the market.

We have acquired already our first 11 properties with another 54 property acquisitions in progress. This should bring our total number of properties on the platform to 65, with a market valuation of about $40 million.”

DomaCom has also demonstrated the versatility of its revolutionary investment model when it recently launched a $250 million crowd-funding campaign to buy the iconic pastoral empire S Kidman & Co, Australia’s largest landholding. The pitch targets investors wanting to keep Kidman Station Australian-owned. Registrations of interest exceed nearly 4,000 investors who have pledged about $58 million.

Naoumidis says: “Clearly there is a strong mood among investors that Kidman Station should remain in Australian hands, and our investment model can allow this to happen. Crowd-funding hasn’t traditionally been associated with pastoral properties, but that’s no reason why it can’t happen.”

The $8 million pre-IPO capital raising was managed by Sydney based Corporate Advisory Firm Axstra Capital along with joint lead manager Pulse Markets. Daniel Coombes, Axstra managing corporate advisor, says: “We are very pleased with the result and to be able to close the pre-IPO ahead of schedule”.

“The strong support received from investors is testament to the potential of DomaCom and the truly innovative pipeline of financial products it has and is developing. With this funding in place, the company can now focus its attention on the next step which is a public listing.”

DomaCom’s key objective is to allow investors to invest into direct real estate in fractions, without the need to buy the entire property. This allows many small investors to pool together and buy large properties. DomaCom’s initial focus is on the self-managed super fund (SMSF) market that boasts more than half a million funds and about $600 billion in funds under management.

To download the full announcement, please click on the link below. 

Omni Market Tide: Could Increased Shareholder Engagement Reduce the AGM Strike Rate?

4th February, By Megan Boston, CEO Omni Market Tide

One of the most notable trends in the 2015 AGM season was the number of listed companies receiving first and second strikes on remuneration reports despite the majority of shareholders not voting on these resolutions.

Last year, nine companies received first strikes against their remuneration report, while three companies received second strikes.

However, of six of the nine companies that received their first strike, fewer than 60 per cent of shareholders voted on the resolutions. In one case, just 17 per cent of shareholders that were eligible to vote on the remuneration resolution participated in the vote. Moreover, one of 2014’s top-performing companies in terms of share price appreciation received its first strike with just 25.09 per cent of votes cast against and just 42.9 per cent of eligible shareholders voting.

An engineering services firm is another example of the trend. It received a vote of 30 per cent against its remuneration report, which was driven by less than 12 per cent of shareholders because of the lack of spread on its share register. This meant more than 85 per cent of shareholders were in favour of the remuneration report.

This situation has occurred despite Australian companies spending large amounts of money on shareholder engagement and registry services. The Corporations and Markets Advisory Committee (CAMAC) discussion paper on the AGM and shareholder engagement found that Australian listed companies spent $200 million on share registry services, $120 million on AGMs and $350 million on shareholder engagement. Yet only five per cent of the top 200 companies are drawing more than 500 shareholders to their AGM.

It all points to low levels of shareholder engagement – if more shareholders were making an informed vote then these companies might have avoided a strike. But the responsibility lies with the company to better engage with their shareholders and make it easier for them to vote.

The question is – what could these companies have done to change the outcome? How could they – and other companies – improve shareholder engagement and ensure that the outcomes of votes are representative of the majority base? And how can they do so in a more efficient and, more importantly, cost effective way?

 As a company’s shareholder base grows, the cost and time associated with driving shareholder engagement only becomes costlier and more time intensive. And as corporate governance continues to evolve, companies should be interacting with shareholders on a far more regular basis.

Investors want to know more about the companies they are putting their hard-earned money into and chief executives expect their investor relations teams to actively and frequently engage with and supply information to shareholders.

The AGM system also needs to be improved to ensure all shareholders have their say more than once a year and that the outcome is representative of the majority. It’s often said that AGMs are symbolic of how we used to do things – paper based, backward in focus, physical in their organisation and process. This leads to low shareholder voting levels and low levels of shareholder engagement.

One solution is to make the process easier by making the voting process mobile through a shareholder voting app. My company, Omni Market Tide, is Australia’s only mobile shareholder voting app and, after launching in July 2015, has already registered two ASX20 companies for the investor relations app and a partnership with registry service provider, Boardroom.

This mobile technology is allowing Australian shareholders to vote through smart devices, rather than rely on the paper and post method, but it’s a relatively new technology.

We hope that by increasing stakeholder engagement throughout the year and giving investors access to company data and communique through mobile technologies, companies can build trust and respect. This is ultimately the best way to avoid being caught off-guard at AGMs whilst enabling shareholders to make informed decisions.

Our international counterparts are doing it well. In the US, 105 companies now hold virtual shareholder meetings, up from 88 in 2014. This method is believed to have boosted shareholder engagement, driving voting participation almost threefold. Additionally, the ability to vote through a mobile platform has seen a 70 per cent increase in voting.

The companies we are currently talking to and working with see the benefit in being a first mover in this area. They understand that mobile technology for shareholder engagement can help eliminate the inefficiencies of trying to manage disparate retail shareholder groups, particularly when needing to mobilise support for things such as a Share Purchase Plan. It also gives them greater insight into the shareholder to better understand their needs, showing their commitment to greater transparency and strong governance.

Australian listed companies can no longer afford to spend money on inefficient methods of shareholder engagement which leads to low voting participation and in some cases, unexpected outcomes at AGMs. Whilst relatively new, companies need to embrace new technologies to increase shareholder engagement and ultimately, get the outcomes that both they and the shareholders deserve.

 

$10 Million Institutional Placement to Drive OncoSil Commercialisation

3rd February 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce a A$10 million Institutional Placement (Placement) to drive commercialisation of the Company’s lead product candidate, the OncoSilTM localised radiation treatment for cancer.

The Placement is by way of Subscription Agreement for approximately 45,454,545 new Ordinary Shares in OncoSil Medical at a price of A$0.22 per share to raise $10 million.

The Company is delighted to receive this level of investment and financial backing at this point and time, and views it as strong validation for the OncoSilTM brachytherapy technology and its global commercialisation potential.

The Placement funds will be used to aggressively drive OncoSil Medical’s commercialisation plans to position OncoSilTM as an innovative, new medical radiation treatment for pancreatic cancer and other solid tumours – which have major un-met medical needs.

To read the full announcement, please click here

Unity Pacific Commences Expressions of Interest Process

2nd February 2016, ASX Announcement

In recent announcements, Unity Pacific Limited (ASX: UPG) (Unity Pacific) advised that the Unity Pacific Board will consider expressions of interest in relation to the corporate vehicle and the assets of UPG that will remain after the sale of 308 Queen Street/88 Creek Street, Brisbane.

On 24 December 2015, Unity Pacific advised that it had entered into a short period of exclusive negotiations with Sentinel Property Group (Senitel), expiring on 31 January 2016, in relation to a conditional offer made by them to fund a buyback of all the Unity Pacific Group securities that it does not currently own.

Unity Pacific advises that during that exclusivity period, Unity Pacific and Sentinel were unable to agree terms in relation to a revised offer.

Given that a number of parties have expressed interest in the corporate vehicle, Unity Pacific now intends to commence a broader expression of interest process (EOI process) in relation to the corporate vehicle and the remaining assets of the group during which it will continue engage with Sentinel which has indicated it would welcome the opportunity to be invited to participate in the formal EOI Process.

To read the full announcement, please click here

Catcha Group Completes Largest Internet Transaction in Southeast Asian History With The Sale of iProperty

2016 is off to an eventful start, with the sale of iProperty now final. The deal marks a significant milestone for Catcha Group and represents the first ever major exit, which is the largest Internet transaction in Southeast Asian history. We’re thrilled to have the opportunity to remain a part of the company’s journey as it embarks in it’s next stage of growth with its acquirer, REA.

Dates are locked in for Wild Digital 2016, back by popular demand! This year will be bigger and better - featuring over 60 speakers, all new workshops and activities. Be sure to save June 8 and 9 in your calendars so you don’t miss out on opportunities to network and connect with Internet leaders from all over the world.

REA READIES FOR EAST ASIA PUSH ON TOP OF iPROPERTY TAKEOVER

The Australian

SYDNEY: REA, majority-owned by News Corp, is paying $580m to buy the rest of the company that it does not own. REA previously owned a 23 per cent stake.

Read more.

DIGI AND IFLIX DEEPEN RELATIONSHIP WITH BUNDLING PACT

Digital News Asia

DIGI Telecommunications and Internet TV service iflix have announced that from Jan 26 onwards, all Digi cusotmers who sign up or upgrade to a Digi SmartPlan 65 or above will receive a free 12-month iflix subscription, valued at RM96 (US$23 at current rates).

Read more.

Folkestone’s Latest Blog – Digital Connectivity – 2015 A Watershed Year But It Is Only The Beginning

1st February 2016

Digital Connectivity – 2015 A Watershed Year But It Is Only The Beginning

2015 was a watershed year for digital connectivity.

We have moved from an information economy where we created data, to an intelligent economy where we are connecting a myriad of objects that can not only generate data but facilitate the sharing of information and real time analysis. The speed of change is unprecedented and inexorable.
Our economic, learning, cultural, and human environments are being transformed. This is especially true for the real estate sector – houses, office, retail, industrial, health and medical facilities, hotels and cities – where digital disruption is having an enormous impact.

Read more.

Best of the Web 

The Digital Transformation of Industries

The conversation about digital technology has shifted over the past five years. No longer seen as the exclusive domain of tech companies or a driver of marginal efficiency gains, digital technology is now considered a powerful enabler of fundamental innovation and industry disruption across the value chain. What big bets are companies making in the digital transformation of their business models and organization structures?

Read more.

The More Things Change – Value Creation, Value Capture, and the Internet of Things

Most “things,” from alarm clocks to Zambonis, the human body includ­ed, have long operated largely “dark,” with their location, position, and functional state unknown or even unknowable. No longer, thanks to the Internet of Things (IoT), a suite of technologies and associated business pro­cesses that allow us to track and count, observe and identify, evaluate and act in circumstances heretofore effectively invisible and beyond reach.

Read more.

The Internet of Things: Mapping the Value Beyond the Hype

The Internet of Things—digitizing the physical world—has received enormous attention. In this research, the McKinsey Global Institute set out to look beyond the hype to understand exactly how IoT technology can create real economic value. McKinsey’s central finding is that the hype may actually understate the full potential of the Internet of Things—but that capturing the maximum benefits will require an understanding of where real value can be created and successfully addressing a set of systems issues, including interoperability.

Read more.

Charter Hall appoints David Harrison as CEO and MD

1st February 2016, ASX Announcement

Charter Hall Group (ASX: CHC) (Charter Hall or the Group) today announced that David Harrison has been appointed Chief Executive Officer and Managing Director (CEO/MD) of the Group, with David Southon electing to step down as Joint Managing Director (JMD) following the Board and JMDs’ decision to move to a single CEO/MD structure.

Charter Hall Chair, David Clarke, confirmed the Board and JMDs have been working towards transitioning to a single CEO/MD  structure over the past nine months as part of their focus on succession planning and building a strong leadership team for the Group.

“Ensuring the Group has the right senior leadership capability and structure to support its future plans has been a key focus for the Board and JMDs over the past three years. Given the Group’s significant growth, the work undertaken by the JMDs on building the leadership  team through a number of key appointments and in positioning the business for the future, we believe now is the appropriate time to move to the single cEO/MD structure,” Mr Clarke said.

David Harrison will assume the CEO/MD role immediately, with founder David Southon to be available to the business for up to 12 months to facilitate a smooth handover and assist with the transition to the CEO/MD structure.

To read the full announcement, please click here

 

Activation of Further Revenue Streams Contributing to Ongoing Revenue Growth from Big Un Limited

1st February 2016, ASX Announcement

Highlights:

  • Revenue continued to outperform expectations, with $650,405 achieved in the December 2015 quarter, a 60% increase on the prior September 2015 quarter ($405,582)
  • The increase represents another period of strong growth with encouraging contributions from new revenue streams including licensing and sponsorship partnerships
  • Strong SME membership pipeline with over 14,000 merchants
  • Further sales distribution licenses and sponsorship opportunities expected to drive growth of additional revenue streams in the March quarter

Big Un Limited  (ASX: BIG, ‘BRTV’ or ‘the Company’ is pleased to provide a review of its activities for the three month period, ended 31 December 2015.

Corporate 

Expectations Exceeded with Continued Robust Revenue Growth 

Strong revenue growth continued for the quarter ended 31 December 2015, with cash receipts of $650,405, representing 60% growth on the prior September quarter ($406,582 September 2015 quarter) and outperforming expectations. The Company previously guided the market towards cash receipts of $600,000 during the December quarter (announced on 25 November 2015).

To read the full announcement, please click here

Bulletproof to Acquire Cloud House

1st February 2016, ASX Announcement

International Acquisition:  Leader in NZ Cloud Services 

  • Bulletproof to acquire Cloud House, New Zealand-based Cloud Services business:
  • Purchase price NZ$1.0m cash upfront, plus up to NZ$4.2m payable based on performance
  • EPS accretive deal represents an initial payment of c.2x run-rate EBITDA
  • Cloud House employees to transition to Bulletproof

Bulletproof (ASX:BPF) is pleased to announce it has agreed to acquire the business assets of Cloud House Limited, the leading Cloud Services company in New Zealand, with offices in Auckland and Wellington. New Zealand’s largest AWS Advanced Consulting partner, Cloud House provides consulting, billing and managed services for its customers on their journey to the cloud.

Bulletproof has agreed to pay NZ$1m to purchase the business assets of Cloud House from existing cash reserves, bringing approximately NZ$3.5m annualised revenues, with around NZ$500kof current run-rate EBITDA to the Company.

To read the full announcement, please click here

 

Crowd Mobile New York Investor Presentation February 2016

1st February 2016, ASX Announcement

Crowd Mobile – What We Do 

  • We are focused on global mobile economy
  • We generate revenue from m-content & m-commerce
  • We receive m-payments directly from Telcos/Apple/Google
  • We have connections into 160 Telcos in 50+ countries
  • Listed on the ASX under code CM8 and on Frankfurt/XETRA under code CM3
  • Our company has been profitable since 2009 and generates free cash flow used fro growth
  • Completed acquisition of Track Concepts, a global m-payments company company in October 2015

A Global Operation – Extended Global m-payment Reach 

  • Offices in Amsterdam (HQ) Budapest and Melbourne
  • Over 60 employees in the group
  • Reach into 50 countries globally
  • 88% of revenue comes from outside Australia
  • Grow opportunities into Africa/LATM/Asia inc China

To view the full presentation, please click here

Altech Chemicals Quarterly Activities and Cashflow Report

1st February 2016, ASX Announcement

Highlights:

  • Altech signs mandate with German KfW IPEX-Bank for project financing
    - Exclusive project finance mandate with German KfW IPEX-Bank
    - Mandate for senior debt, including German Export Credit Agency (ECA) insured debt
    - Approx. US$40m of ECA cover project debt
    - Balance of approx. $15m senior debt
  • Appointment of HPA sales & marketing manager (China)
    - Mr Martin Ma appointed to develop the HPA business in China
  • Altech receives Letter of Interest (LOI) for German export credit cover
    - LOI received from Euler Hermes for German ECA cover
    - Around 55% of plant and equipment sourced from Germany & additional 10% from Europe
    - Debt supported by ECA cover is typically at attractive conditions, including long tenure and low interest rates
  • Optimisation of kaolin benefication plant location
    - Kaolin benefication plant to be located at the Company’s HPA plant site in Johor, Malaysia
    - Detailed design and optimisation work continues

To read the full announcement, please click here

Analytica Quarterly Cashflow Report for Quarter Ended 31st December 2016

29th January 2016, ASX Announcement

Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System, today released its Appendix 4C – Quarterly Cashflow report for the quarter ended 31st December 2016.

Receipts from sales of PeriCoach in Analytica’s key markets of Australia, the UK and the US totalled $47,000 while marketing and sales expenditure for the quarter totalled $714,000. During the quarter, Analytica developed distribution agreements with partners in the UK. One of these partners is the number one supplier of pelvic health devices to consumers in that market. By the June quarter 2016, Analytica also expects to have identified and completed distribution agreements with a number of distribution partners in the Australian market. These agreements could be important in assisting the growth of PeriCoach sales in the future as the company seeks to partner PeriCoach with a major multi-national corporation.

R&D expenditure was $424,000 for the quarter. The release of PeriCoach in the USA, UK and Australia provided Analytica with an important opportunity to engage with specialist pelvic floor clinicians in those countries. These relationships combined with the deep experience of the company’s clinical advisory boards has enabled Analytica to publish papers and testimonials and importantly its has assisted in the on going development of PeriCoach. The company has continued to exhibit PeriCoach at major international urology and gynecology conferences and continues to receive very positive feedback.

Analysis of the significant amount of data being collected from PeriCoach users is providing valuable feedback for the development of next generation of PeriCoach. Through sales of PeriCoach, Analytica is building the world’s largest database on the pelvic floor muscle exercise. Development of future generations of PeriCoach will ensure more detailed and extensive data becomes available. In order to stay at the forefront of treating stress urinary incontinence Analytica will make a significant investment in the development of analytical tools to utilise this data, providing superior treatment options for health providers.

Continuing to develop PeriCoach will not only extend the company’s leadership but may also open additional higher value markets and increase the opportunity to partner with multi-national medical device companies.

Analytica will continue to concentrate on specific market segments while focussing on the further development of the PeriCoach.

During the quarter, Analytica also made solid progress with its post-approval clinical trial, which will provide independent data and further evidence of PeriCoach’s value. Three additional trial sites were added with additional patients being enrolled.

The cash balance as at 31st December was -$6,000 which was assisted by a loan from the Chairman of $277,000, from the previously announced $400,000 loan facility. However, this cash balance did not include the benefit of the R&D tax incentive of $1.901 million received after quarter end on 18th January. As at 27 January 2016, Analytica’s cash balance was $1.197 million.

To read the full announcement, please click here

Alpha Deal Group Sees YuuZoo Fair Value at S$1.40 Per Share

27th January 2016, YuuZoo

Alpha Deal Group (“ADG”), a leading New York based research and advisory firm that caters to institutions, investment banks, and Csuite deal team executives, yesterday released a 27-page report on YuuZoo. ADG concludes there is massive upside on YuuZoo’s share price, stating they view the fair value of the company at S$1.40 in view of recently signed agreements and YuuZoo’s expansion into a B2C business model.

The ADG report notes that the share price is currently trading at a massive discount. The current share price is in line with YuuZoo’s historic B2B focus rather than being aligned with a company exposed to high-growth Asian e-commerce and games markets.

Prior to 2013 YuuZoo’s revenue growth was driven by its B2B marketing and operations (composed of franchisees, network and payment clients). However, moving forward, YuuZoo’s management is investing substantially in consumer engagement, translating to much higher monetisation of its consumers. The report notes that in 2014 YuuZoo saw ecommerce as the largest revenue contributor. ADG expects this growth in ecommerce to continue, and also to generate new revenue from higher margin advertising and games.

ADG reports that YuuZoo, through its unique partnership model, is able to quickly grow its international business. With new franchise operations in UK, Korea, Turkey, Central and Eastern Europe, games (mobile and e-sports) launching with strong partners in China, JV operations commencing in Nigeria, with Africa’s largest TV network – NTA and a distribution agreement with Etisalat, the Company is expecting strong growth in Q4/2015 and throughout 2016.

To read the full announcement, please click here

Booodl; From E-Commerce to Me-Commerce: Are You Ready?

I wanted to share our latest post. Let me know what you think.

Personalised customer experience will play a big part in retail loyalty this year. The hype was all about e-commerce and now it’s about me-commerce; using data to know your customers and craft delightful in-store shopping experiences around those insights. But retail stores aren’t hitting the mark click to read more.

George Freney
Booodl Founder & CEO
www.Booodl.com

Global Audience Demand by Parrot Analytics: Sci-Fi, The Long Tail and Chinese Audiences

Which of the 90′s shows are still in-demand? 

In this week’s featured insight, we analyze the audience demand for shows that aired in the 90′s in the US and the UK and find the top 90′s shows in those markets.

Read more.

Most In-Demand Genres in Saudi Arabia

We find that Drama is one of the most in-demand genres in Saudi Arabia. Find out which other genres are in-demand.

Read more.

The Most In-Demand Sci-Fi Shows in China

Bringing you the current top ten most in-demand Sci Fi shows in China – withHeroes RebornThe Expanse andDoctor Who topping the list!

Read more.

In case you missed it

Top 10 Most In-Demand Digital Originals in the US (13- 19th January, 2016)
by Parrot Analytics & The DEG 

Report: Game of Thrones trumps demand for Netflix Originals 
by Screen Daily

Martin Jeptack Shareholder Update January 2016

29th January 2016, ASX Announcement

This newsletter is focused on the recent marketing activities of Martin Aircraft Company to give shareholders the background behind the recent announcements and also to outline how a marketing and sales cycle works within the aviation business with our target First Responder customer. The update covers a number of other topics including an overview of manned flight display in China, announcement of the formation of “Iron Man” clubs in China, and our participation at Intersec 2016 in Dubai.

The next newsletter will highlight some of the technical achievements to date and update shareholders on the production set up progress.

Update on Sales Initiatives for 2016 

As detailed in previous shareholder updates and the recent AGM, Martin Aircraft Company is deploying a beachhead marketing strategy focused initially on the First Responder market. This “chasm crossing” best practice model, is a tried and tested route for marketing distributive technology into mainstream markets, particularly those customers who are quite traditional and have long procurement cycles.

We are deploying this model through a two tier approach, both acting directly with First Responder clients and, when appropriate, establishing Alliance Partnerships with approved distributorships to secure market reach and penetration.

To read the full announcement, please click here

Analytica Announces Two New PeriCoach Distributors for UK and Ireland

29th January 2016, ASX Announcement

PeriCoach, an innovative pelvic floor muscle training system, launched in the UK market in June 2015, have announced the appointment of two new distribution partners here.

Developed by Australian medical device company, Analytica Medical Ltd, PeriCoach is a medical device and app that helps women strengthen their pelvic floor muscles. Combining the latest biosensor technology with an easy to use app, this home Kegel exerciser has been specifically designed to offer women the choice of using it either on their own or with the help of a healthcare professional in order to reduce or stop bladder leakage.

A distribution partnership between PeriCoach and Savantini Ltd has just been agreed. Savantini, who have over 20 years of experience selling pelvic floor products direct to consumers, are the company behind both Kegel8 and Stressnomore labels (www.kegel8.co.uk and www.stressnomore.co.uk) Savantini Ltd is the UK’s leading healthcare supplier for medical and wellbeing products for both women and men. Stephanie Taylor, founder and CEO of the company has said: “We are thrilled to be expanding our product offering to our customers with the innovative PeriCoach system – we know our customers will love it.”

A second agreement has been made with Elgenia Health, which is a newly established women’s health distributor in London, specializing in bringing state-of-the-art women’s health products to market for a wide range of healthcare professionals.   Founder Eleanor Gardner says: “We constantly strive to find new innovative products that will assist clinicians and enhance patient outcomes.  We source new technologies and aspire to be at the forefront of pelvic health – it is for that reason, we have specifically chosen the PeriCoach system. Its’ very unique offering of being able to provide an online medical portal to support patients and clinicians fits in with our values of supporting healthcare professionals.”

To view the full announcement, please click here

How Virtual Reality Could Change Moviegoing – 8i

28th January 2016, CNN By Lorenza Brascia and Stephanie Elam

You’re standing on the edge of a cliff, hundreds of feet above a snaking river. Your palms are sweaty. Your heart is beating fast.

Someone tells you to jump, but everything in your body screams, “Don’t do it!” Your brain is having a hard time overriding what your eyes are seeing in the goggles you wear on your face.

“Jump!” you’re told again.

It’s actually a harmless request, since this is virtual reality. Instead of a cliff’s edge you’re standing on a carpeted floor in a lounge at the Sundance Film Festival and you’ve been watching “The Climb,” a brief film made by 8i, a startup that creates virtual reality, or VR, content.

“Your logical side is saying, ‘I’m in a headset. I’m in this room.’ But your emotional side is saying, ‘I’m on a cliff. I could die here. I don’t want to jump,’” said 8i co-founder and CEO Linc Gasking.

Virtual reality, the emerging technology that is poised to transform video gaming, is also coming to the movies. Here at Sundance 2016, more VR experiences than ever are being showcased as part of the film festival’s New Frontier program, which celebrates new or alternative forms of creative expression.

Ramzi Haidamus, president of Nokia Technologies, says the development of VR for filmmakers has been a long time in the works. He recently spearheaded OZO, the first virtual-reality camera designed specifically for Hollywood-grade filmmakers. Haidamus has been experimenting with virtual reality for years and says the technology is making huge strides.

“I couldn’t jump,” Haidamus said after trying out “The Climb.” He credits audiences’ hunger to be closely connected to stories and VR’s appealing price point as being a “perfect storm” for the technology this year.

To read the full story, please click here

Leaf Resources Update; New Technologies, 30 Hottest Bio-based Molecules and Sustainable Eye Wear

New Pathways to affordable, everyday materials

How the new generation of advanced technologies is changing the world

A new generation of advanced technologies, based primarily in the United States but active in Europe and around the world, is changing our way of thinking about what a factory has to look like, one that produces the materials of everyday life — clothing, foods, vehicles, buildings, roads and devices. Read more>>

The 30 hottest bio-based molecules for 2016

Cellulosic Sugars are Hot!

In Florida, the Digest recently released the 30 Hottest Biobased Molecules for 2016, as voted by the Digest’s global readership. Read more>>

New bio-based sustainable eye-wear

Awear specialized bio-made sustainable optical glasses and sunglasses

Charmant USA recently announced the launch of a new bio-based sustainable eyewear brand. Read more>>

Leaf Resources ranks in the Australian Cleantech top stock for 2015

Cleantech top 10 stock from 2015

Looking to invest in the Cleachtech sector, then take a peek at the top 10 stock. Read more>>

Crowd Mobile Update on Track Earn-Out Payments and Debt Restructure

28th January 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) is pleased to provide an update in relation to earn-out payments due pursuant to the Track Concepts’ (“Track”) acquisition and a restructure of existing debt arrangements.

Track earn-out payout 

As part of the consideration for the Track acquisition, Crowd Mobile agreed to an earn-out payment to the Track vendors based on the financial performance for the 2015 calendar year. The earn-out has been agreed at €4.5 million (c$7.0 million AUD), reflecting performance at the upper end by Track for the 2015 calendar year. The payment terms for the earn-out are as follows:

  • €2.0 million (c$3.1 million  AUD) in January 2016
  • €2.5 million (c$3.9 million AUD) in June 2016

The January 2016 earn out payment will be funded from existing operating cash flows.

Commenting on the Track earn out payment, Crowd Mobile CEO Mr Domenic Carosa said:

“The earn-out payment agreed is at the top end of the capped earn-out which is reflective of Track profit performance. This is a very positive outcome for Crowd Mobile and provides strong profitability and cash flow momentum for 2016.”

To read the full announcement, please click here

Watch Booodl on Sky News

Last week, Founder and CEO of Booodl, George Freney, was interviewed on Sky News. Please watch the video by clicking the image below.

ABOUT BOOODL

Booodl is an app that simplifies local shopping by; making it simple to list products you want to buy, locating local stores through geo-notification push reminders and location-based search, instant messaging with stores, and in-app purchasing.  It creates value for retailers by increasing foot traffic to stores, providing a new way to communicate with customers, increasing sales and giving insight into consumer behaviour.

BioDiem Raises Over $580K

Entitlement Offer and Placement raises $589,793

BioDiem Limited (“BioDiem” or “the Company”) advises that it has now completed the issue and allotment of entitlement and shortfall shares under the shortfall facility of its recent Non-Renounceable Entitlement Offer.

Read more.

Appointment of Professor Arthur Li to the BioDiem Board

BioDiem Ltd is pleased to announce the appointment of Professor Arthur Li, as a non-executive director, to the BioDiem board.  Prof Li was previously a director of BioDiem from 2010 until 2014.

Read more.

New way of trading BioDiem shares

Please register your interest or find out more about trading BioDiem Shares here.

Prescient Therapeutics Quarter Summary and Key Activities

25th January 2016, ASX Announcement

Prescient Therapeutics Limited (“Prescient” or “the Company”) provides the following Appendix 4C in relation to the quarter ended 31 December 2015.

In January 2016, the Company carried out investor roadshows in the US meeting key instructions and investment advisors and also presented at Biotech Showcase 2016 in San Francisco and NobleCon12 in Florida.

Cash at 31 December 2015

Cash at the end of the quarter, as detailed in the attached Appendix 4C, was approximately $1.93 million.

Subsequent to the end of the quarter the Company has now received its 2014/2015 Research and Development Incentive Grant and Overseas Finding Grant amounting to $463,358.

Key activities during the quarter

During the quarter, the Company announced a Share Purchase Plan (SPP) fully which was underwritten up to a target amount of $1.03 million to underpin next stage development of its lead oncology costs. The SPP closed oversubscribed with $1.2 million worth of subscriptions received. All applications under the SPP were scaled back on an equal basis and a total of 17,174,368 full paid original shares were issued at $0.054 (5.5 cents) per share, being a 20% discount to the 5 day volume weighted average price (VWAP) before 23 November 2015.

To read the full announcement, please click here.  

Folkestone’s Latest Blog – SMF’s Influencing Australia’s $2 Trillion Superannuation

SMSF’s – Significantly Influencing Australia’s $2 Trillion Superannuation

Australians are increasingly turning to Self-Managed Super Funds (SMSF’s) to grow their wealth and prepare for ‘life after work’. Since 2010, the number of new SMSF’s has grown by more than 6% pa, and has quickly become a heavy weight contributor to the $2 trillion superannuation industry.

Popularity Of SMSF’s On The Increase

According to the ATO‘s most recent report on SMSF’s, between 30 June 2010 and 30 June 2015, the number of SMSF’s grew from 414,168 to 556,998. This rise in SMSF’s has allowed a major milestone to be reached for 2015, with more than 1 million Australians using SMSF’s as a wealth creation tool for their retirement.

SMSF assets are up a staggering 66 per cent, to $590 billion in the past six years. Over the same period, the average assets of an SMSF grew by 24 per cent to $1.1 million, while the average assets held per member increased by 24.7 per cent to $562,000.

Read more.

Best of the Web - Superannuation

Our Best of the Web puts you in touch with interesting papers and presentations on real estate investing that we have found on the web.

Please see the link below for interesting facts and information on Superannuation.

Read more. 

8i Are the Company Helping Filmakers Put You Inside Movies

21st January 2016, Wired By Angela Watercutter

Look, you’re never going to get to drive the Fury Road with Max and Furiosa. You’re just not. It’s a bummer, but it’s true. However, if you want a mini taste of that post-apocalypse life and you happen to be at the Sundance Film Festival sometime in the next week, then you’re in luck: 8i’s virtual reality experience The Wasteland awaits.

The movie places viewers (wearing an HTC Vive VR headset) in a dystopian desert alongside a female warrior as a hacked-together dune buggy drives up. Because the Vive’s Lighthouse system tracks your movement, you can walk around the desert, approach the vehicle, even look at the weapons the warrior is carrying. But what the best part isn’t all the cool dystopia stuff—it’s how the wasteland was made.

If a VR filmmaker had wanted to make Wasteland the hard way, they would have had to render the entire desert setting, car included, using CG. Then they’d have to do motion-capture with their actors and take that mo-cap performance and paint a face and clothes onto each character. 8i’s technology, however, lets filmmakers capture entire performances with off-the-shelf cameras and then place them in pre-existing environments, creating a fully navigable 3-D VR movie that’s far more immersive than the 360-degree videos most have seen.

“What you’re seeing there is this integration, using our tools, of a human that’s recorded in real life, completely dressed and acting, a CG element (the car), and a photographic environment that was a real place,” says 8i CEO Linc Gasking. “It allows storytellers, like the storytellers at Sundance, to be able to finally for the first time be able to put realistic humans into a story for virtual reality.”

Wasteland is just one of four VR projects 8i is bringing to Sundance as part of their #100humans program. (There are other companies working on volumetric capture for VR, from Lytro to Uncorporeal, but 8i is the only one confirmed to be bringing multiple experiences to Sundance.) The others show a mother leaving a message for her young child, a Roman gladiator who’s a dead ringer for The Karate Kid’s Johnny, and a climber on a vertigo-inducing ledge in the Grand Canyon. They’re all very different from each other, but they’re also different from a lot of the other VR experiences at Sundance. They’re meant to show filmmakers what they can do with 8i’s tech, not necessarily show what a filmmaker has done.

To read the full article, please click here

8i Unveils First Volumetric VR Project Featuring Real Human Actors at Sundance

22nd January 2016, Medium By Linc Gasking

Throughout history, storytellers have always strived to create realistic depictions of their fellow man or woman. Cavemen scratched stick figures into walls; Renaissance painters spent months, if not years, capturing the likenesses of their muses and benefactors; and early photographers worked to master exposure times and shutter speeds. Artists’ scopes were limited only by their respective era’s technical limitations.

Today, with the newest advancements in the field of video capture technology, we’ve come to what I believe to be the final, most realistic medium possible: telling volumetric stories in virtual reality or augmented reality. This week at the Sundance Film Festival’s New Frontier, we’re excited to unveil “#100humans,” the first volumetric VR project which pushes the boundaries of storytelling by bringing real human actors into realistic virtual experiences.

Volumetric VR gives you the ultimate feeling of reality. Not only can headset-wearing users see scenes with three-dimensional humans — who actually look like real people, as opposed to the glassy-eyed bots of CG — but they can also physically walk around these “characters” and watch them from any angle. Unlike film, there are no “takes” or “shots” in VR that are edited in post-production — it’s much more fluid as the viewer is the one framing the scene and choosing their own perspective. In that sense, the viewer takes that role from the director, which opens up entirely new possibilities for storytelling and acting.

The goal of our #100humans project was to begin a journey and discover something about what this new medium of volumetric VR means for storytelling. Created by 8i’s award-winning team of visual effects, technology and film industry veterans, including Emmy Award-winner Rainer Gombos (“Game of Thrones”, “Cosmos”), #100humans explores new ways for the audience (in other words, you, the viewer) to experience virtual scenes, featuring human actors, in a way that was never possible before.

To read the full article, please click here

Tesserent Cyber Security IPO Closes Early and Oversubscribed

  •  Maximum of $7m raised
  •  Trading on ASX expected to commence shortly

Tesserent Limited has closed its initial public offering (IPO) oversubscribed, successfully raising the maximum amount of $7 million. The issue closed on Wednesday 20 January 2016 at AEST 5pm, approximately two weeks ahead of its scheduled close of 5 February. The company’s shares are expected to begin trading on the Australian Securities Exchange (ASX) shortly.

Tesserent is a direct provider of Security-as-a-Service to small and large organisations to protect computer networks. The IPO, managed jointly by Terrain Capital and Novus Capital, received strong backing from investors encouraged by the opportunity to invest in a profitable company with over 190 customers in 11 countries and rapidly growing.

Tesserent will list on the ASX with a market capitalisation of $20.5 million, based on the $0.20 per share offer price.

“We have been overwhelmed by the investor support, and it’s a fantastic endorsement of our company, technology and our people,” said Tesserent’s Managing Director Keith Glennan.

Tesserent already services customers in Australia and overseas including the United Kingdom, Hong Kong, South Korea and the UAE. With the growing need for cyber security Tesserent is positioning itself to win much more local and global business by providing small, medium and large organisations with resilient, safe and simple security solutions.

Funds from the IPO will allow Tesserent to expand its IT infrastructure and sales & marketing programs and support Tesserent’s ongoing research and development programs. Tesserent’s Managed Security Service Provider Platform is a subscription-based cloud service that services strong demand in the Security-as-a-Service market, forecast to increase from $US12.5 billion in 2015 to US$26.9 billion in 2019.

APN Convenience Retail Property Fund Update

21st January 2016, ASX Announcement

In light of Monday’s announcement by Woolworths Limited in respect of the Masters business, APN is providing an update to the market on the APN Convenience Retail Property Fund (the Fund).

As previously advised to the market, the Fund is currently being established and includes a property agreed to be leased to Masters which is currently on APN Property Group Limited’s balance sheet.

APN is committed to the Fund and its investment strategy. The Fund is founded on quality, long term cash rental income streams from non-discretionary retail tenants.

In the current low rate environment, APN believes this strategy is very well suited to deliver attractive risk-adjusted returns, including high monthly income yields to investors. We believe this product is ideal for self managed superannuation funds and other investors seeking commercial property investments with strong and regular income returns.

To read the full announcement, please click here.  

Big Achievements for Proteomics in December Quarter 2015 – Full Report Available

21st January 2016, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to provide the following update on its business activities for the three month period from 31 December 2015.

Highlights:

  • PromarkerD Commercialisation progress: Company has now established active, ongoing commercialisation dialogue in key global markets – USA, China and Japan.
  • US Patent granted for PromarkerD: Critical milestone in the development and commercialisation pathway, and is valid until September 2031.
  • Growth in Analytical Services business: On target for year-on-year growth of 25%.
  • Company awarded Health and Biotechnology Export Award at Western Australian 2015 Industry and Export Awards.

December 2015 quarter commentary 

The December quarter was another solid quarter for PILL. The Company continued to ficus significant effort on the commercialisation of PromarkerD, the world’s first proteomics-derived predictive (prognostic) and diagnostic test for the diagnosis of Diabetic Kidney Disease and made further progress on this front. At the same time, the Analytical Services business continued to perform in-line with Company targets, and remains on target to deliver a 25% year-on-year growth.

To read the full announcement, please click here

Prescient Therapeutics Presents at NobleCon12

21st January 2016, ASX Announcement 

Clinical stage oncology company Prescient Therapeutics Limited (ASX:PTX), today announced that Director, Mr Steven Yatomi-Clarke, has presented at the NonbleCon12 – Noble Financial Capital Markets’ Twelfth Annual Investor Conference at Club Med in Sandiper Bay, Florida.

To view a recording and a copy of the presentation materials, please click here

Big Un Limited December 2015 Quarter Revenues Above Guidance

21st January 2016, ASX Announcement

Highlights:

  • Big Un Limited to report continued strong growth for the quarter ended 31 December 2015 with cash receipts of $650,405 (September 2015: $406,582) well above the Company’s previously announced guidance of $600,00
  • 60% increase on the September quarter represents another period of robust growth with an encouraging contribution from new revenue streams including licensing and sponsorship from Pillar Two of the Company’s business model
  • Strong revenue growth expected to continue in the March 2016 quarter

Big Un Limited (ASX: BIG, ‘BRTV’ or ‘the Company’) is pleased to provide an update on its performance for the quarter ended 31 December 2015.

The Company previously guided the market towards cash receipts of $600,00 during the December quarter (announced on 25 November 2015) and is pleased to announce it has exceeded expectations, delivering cash receipts totaling $650,405.

Cash receipts for the December quarter of  $650,405 represent 60% increase on the September quarter (September 2015: $406,582), signifying another very strong quarter of growth.

To read the full announcement, please click here

 

D’Arcy Polychrome Seeks Further Capital to Expand Sales into US After Securing Over $650,000

D’Arcy Polychrome Limited (“DPL”) seeks NZD2 million of new equity investment to fund the commercialisation of drikolor™, a proprietary and high margin colouring system for paint and concrete. drikolor delivers colour through dry granulated pigments that rapidly mixed into base paints and concrete. Please click here for a short video introduction.

The company’s technology means drikolor can create new revenues for outlets such as design stores that recommend colour schemes, but have not previously been able to sell colour. It opens up the opportunity to sell colour to a range of homeware stores, designers and online channels that haven’t sold these mediums before, and gives them the potential to curate their own proprietary palettes.

DPL has already secured a sales agreement with Ixom (formerly Orica), which sells its colourant technology exclusively in NZ for concrete. DPL represents a global, high growth investment opportunity. DPL has also opened a US sales office in Culver City, CA to target US homeware stores.

The Information Memorandum contains an offer to raise up to NZD2 million through the issue of new shares at a price of NZD2.31 per share. Assuming NZD2 million is raised these new shares will represent 24.97% of the Company.

DPL will use investor funds to further build a sales and marketing team to execute on opportunities primarily in the United States following strong interest from leading architecture and design customers like Dwell. DPL also intends to streamline its manufacturing process to improve cost efficiencies; and to further its existing intellectual property.

The founding team has an in-depth knowledge of the paint industry, including considerable international experience. Their know-how, experience and skill provide another difficult to replicate advantage for the Company in dealing with both designers and the paint industry.

The offer has a minimum of $350,000, which has been exceeded through pre-commitments from the investor directors and the Chair. D’Arcy has so far secured over $600,000 through this offer.

For the Information Memorandum please click here. Thank you for your consideration of this investment opportunity. I look forward to learning of your interest to review further. DPL’s management, directors and I would be pleased to meet with you or your colleagues to discuss this further at your convenience.

OncoSil Appoints Independent Non-Executive Director

21st January 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) is pleased to announce the appointment today of Dr Chris Roberts as an Independent Non-Executive Director of the Company, with immediate effect.

Dr Robert is a highly experienced director and senior executive with 40 years’ experience in the medical innovation space. During this time he has served on the boards of a number of ASX listed companies as well as research institutions and government entities.

Dr Roberts has forged a long and successful career in the medical device sector. He was Chief Executive Officer/President of Cochlear Limited (ASX: COH) from February 2004 to August 2015. Cochlear is the global market leader in inplantable devices, such as cochlear implants, for the hearing impaired. Dr Roberts was primarily responsible for the significant increase in the Cochlear Limited’s sales from $348m in 2005 to $926m in 2015.

To read the full announcement, please click here

MedAdvisor Strengthens Board of Directors with Appointment of Ms Sandra Hook

19th January 2016, BusinessWire

MedAdvisor Limited (ASX:MDR) an Australian software developer focused on improving health outcomes by placing patients at the centre of connected health platforms, today announces the appointment of Ms Sandra Hook as Non-Executive Director.

MedAdvisor Chairman, Mr Peter Bennetto, said: “On behalf of the Board of Directors, I am delighted to announce Ms Hook’s appointment. She brings a wealth of CEO-level experience in running successful television, print and digital businesses and is an important addition to the Board as MedAdvisor transitions from a software development company to a sales and marketing led business.”

Ms Hook said, “I am very pleased to join the MedAdvisor Board as Non-Executive Director. I look forward to being part of the Company as it works to capitalise on its significant short and long term opportunities.” Ms Hook will be issued with 5,000,000 options at $0.08 subject to Shareholder approval at the next AGM.

To read the full article, please click here

Wholesale Investor Client Achievements in 2015 – Major milestones, Share price growth, capital raised and company highlights

Welcome to 2016. Whilst it still feels a bit strange saying that, it is amazing how quickly 2015 came and went.

2015 has been an extraordinary year for our clients and this special update provides a snapshot of what they have been able to achieve.

We encourage you to register your interest in the companies, attend our upcoming live Showcase event at the ASX or follow them on our website.

At Wholesale Investor, we are proud to announce that we have recently crossed off several important milestones. In 2015, we recently passed 14,000 subscribers, as well as hosting 21 events across 6 countries to over 3000 attendees. In the last 12 months, we have seen over $100mill of capital raised and our listed clients achieving up to 300% growth.

We have a number of exciting events coming up soon and we look forward to networking with you in the near future.

12 Retail Predictions for 2016 from Booodl

I hope you had a good break. We certainly did, and now we’re back ready for a cracking 2016. It’s off to a flying start: we had a great interview on Sky News (clip coming next week) and we found out Booodl retail store profiles appeared in Google search results over 600,000 times during the busy holiday period. You can read all about what that means for our retailers here.

As we prep for, anticipate and hopefully help shape the retail tech trends of 2016, we came across an invaluable resource from Vend; a leading retail point-of-sale provider. Their 12 forecasts and whitepaper are a must-read and shed light on the issues that will have a big impact on the retail industry this year. Here’s our take on a few that stood out to us:

Get the Vend Whitepaper here.

Thanks again for your continued support and interest in Booodl. Together let’s make this year a great success.

George Freney
Booodl Founder & CEO
www.Booodl.com

Folkestone Maxim A-REIT Fund Significantly Outperforms in 2015

MONTHLY REPORT

December 2015

The Folkestone Maxim A-REIT Securities Fund generated a total return of 16.8% in 2015, outperforming the S&P/ASX300 A-REIT Accumulation Index by 2.47% (on an after fee before tax basis).

The December 2015 Monthly Report provides a snapshot of the Fund and A-REIT sector’s performance in 2015, and our outlook for 2016.

Read more.

SECTOR PERFORMANCE

December 2015

• A-REITs generated a total return of +4.0% in December outperforming equities (+2.7%) and significantly outperformed for the year: +14.4% vs. +2.8%;

• Diversified A-REITs were the best performing A-REIT sector for the month (+6.5%) and retail A-REITs were the best performing for the year (+16.0%);

• A-REITs currently trade on a 5.0% dividend yield, a 2.18% premium to 10 year bonds, and a 37% premium to NTA; and

• Australian A-REITs outperformed other global REIT markets in December and was the second best performer in the year to December.

Read more.

Analytica Receive R&D Tax Incentive Receipt

18th January 2016, ASX Announcement

Analytica Ltd (ASX: ALT) is pleased to announce the receipt of $1,901k from the Australian Taxation Office under the Research and Development Incentive related to the financial year to 30th June 2015.

The research and development tax incentive is an initiative of the federal government to assist small companies to invest in essential research and development to be internationally competitive with new innovative products. This incentive is a welcome boost to our research funding and Analytica is grateful for the support.

The continuing investment in the research and development of the PeriCoach® has led to a best in class, non-pharmaceutical, non-surgical treatment for pelvic floor muscle disorders, particularly stress urinary incontinence and sexual function. Pelvic floor muscles exercises are recommended by the American College of Physicians as a first line treatment for urinary incontinence.

To view the full announcement, please click here.   

APN Property Group Earnings Upgrade

18th January 2016, ASX Announcement

APN is pleased to announce that it has upgraded its full year Operating Earnings Guidance by approximately 56% to between 3.20 and 3.50 cents per share, following the determination of market based performance fees for the 6 month period ended 31 December 2015. Further information, including a detailed review of year to date performance, will be included in APN’s interim financial report scheduled to be released late February 2016.

Operating Earnings is used by Management as the key performance measure of APN’s underlying performance. Its excludes certain items recorded in the income statement including discontinued operations and fair value movements on the Group’s co-investments.

To view the full announcement, please click here.  

RewardBet Granted Australian Patent

On December 24th, RewardBet was granted its Australia patent. Upon renewal fees, this provides patent protection until 2031.

This is our fourth granted patent (others being South Africa, Singapore and New Zealand), but our local market in Australia is also considered one of the most competitive so it’s an enormous advantage for an operator. With advertising expenditure north of $100M per annum, the opportunity to have a patent protected product is a game-changer.”

RewardBet currently has agreements and commercial arrangements with:

  • Kiron Interactive – worldwide licensing agreement for virtual racing and sports
  • Luxbet – Australian bookmaker linked to RewardBet’s proof of concept site
  • NDA with multiple Australian Totalizators
  • NDA with Asian Totalizator
  • NDA with USA based Totalizator
  • NDA with Asian based gaming machine manufacturer
  • NDA with Australian/EU based gaming machine manufacturer.

ABOUT REWARDBET

Described as one of the most innovative gaming developments in decades, RewardBet is a patent protected (50+ countries; granted and pending) and award winning software product designed to significantly enhance the betting experience for customers and increase revenue for operators across Racing, Sports and Casino.
With a major global licensing agreement signed and many very forward implementation discussions with operators including four Tier 1 totes, RewardBet is seeking funding for resources to implement current opportunities and invest in future B2B licensing deals.

 

Parrot Analytics: Global Audience Demand

This week, we bring you exclusive insights on audience demand for Golden Globe-nominated and winning shows and the shows that returned to TV this month such as Downton Abbey and American Horror Story - around the world, across platforms direct to your inbox! We then share the most in-demand crime dramas in Russia right now.

The week also marked the first time a Digital Originals Intelligence Report was released in the industry, shedding more light on audience demand for Netflix, Amazon, Hulu & Crackle originals. Get the report here today. 

Golden Globes 

What does the demand for 2016 Golden Globe-nominated & winning shows look like? In this week’s featured insight, we analyze the 2016 nominated TV shows and rank them in terms of audience demand for those shows in the US.

Read more.

Demand for Returning Shows

We are anticipating the January return of our favorite shows such as iZombie,Galavant and others.

Which of these returning shows are people most looking forward to, as measured by audience demand for them?

Read more.

Exclusive: Access Audience Demand for Digital Originals

For the first time ever in the industry, we release an intelligence report detailing the demand for twenty SVOD-exclusive titles in ten global markets.

Read more.

The Most In-Demand Crime-based Dramas in Russia

Bringing you the current top ten most in-demand crime-based drama in the Russia. Find out who tops the list.

Read more.

Crowd Mobile Trading Update – Record Results

18th January 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) is pleased to provide a trading update to the market using the following, unaudited metrics:

  • Revenue of $4.1 million for the month of December 2015 (Nov-15 $4.0 million)
  • EBITDA* of $1.3 million for the month of December 2015 (Nov-15 $1.1 million)
  • Billed message volume of 2.12 million messages for Q2 2016 – up 74% on PCP (Q2 2015: 1.22 million) and 7% higher on the previous quarter (Q1 2016: 1.98m)
  • Debt Facilities increased by EUR3.0m (c%4.6m AUD) by existing European bank 

*EBITDA (Earnings Before Interest, Tax, Depreciation & Amortisation

Commenting on these results, Crowd Mobile CEO Domenic Carosa said:

“Its has been an exciting quarter for Crowd Mobile with many important goals achieved following on from the Track Holdings acquisition, completed in Europe at the end of October 2015. We have expanded our app portfolio with the launch of 5 new apps whilst executing supply agreements to launch Crowd Mobile services into South America and more deeply into Asia. This strong performance combined with a significant increase in our  global footprint will further ensure our revenues and profitability improve over the longer term.”

To view the full announcement, please click here.  

Atomo Secures US$6M from the Global Health Investment Fund

January 13, 2016

The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance

The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo Diagnostics (Atomo) to support scale-up of Atomo’s production operations and expansion of commercial activities related to the AtomoRapid™ rapid diagnostic test (RDT) platform. Funds will also be used to commercialize a self-test solution for HIV and other infectious diseases.

Structured by JPMorgan Chase & Co. and the Bill & Melinda Gates Foundation, with founding support from Grand Challenges Canada, KfW and SIDA, GHIF focuses its investments in companies addressing key global health challenges. Curt LaBelle, MD, Fund Manager of GHIF said, “We are committed to financing initiatives and technologies that can significantly benefit global health and we are thrilled to support Atomo. We believe that the company’s unique and innovative rapid test solutions support point-of-care testing across a variety of settings and have many exciting applications in both developing world and developed markets.”

As part of the collaborative funding agreement, GHIF and Atomo have made global access commitments to support and facilitate the launch and commercialization of Atomo’s professional use and self-test products in low and middle-income countries to ensure that they achieve the greatest possible global impact.

Rapid testing in near patient settings is well established and enables quick diagnosis of many types of diseases and conditions using only a small drop of capillary blood from the fingertip. However, current generation lateral flow rapid test kits require multiple test components to perform a test, making them unsuited for use outside of the laboratory. User errors are common with these kits, even among clinicians, and they are generally considered unsuitable for self-testing. Atomo’s RDT solutions replace these multi-component kits with a single integrated user-friendly device, designed specifically to simplify rapid testing and support consumer self-testing.

John Kelly, CEO of Atomo, said “Our mission has always been to provide the market with products that meet the needs of users.  We set out to develop a solution to obsolete the current generation ‘bits in a box’ test kit format, responsible for hundreds of thousands of errors and incorrect diagnoses globally each year. The investment from GHIF not only enables us to scale up our global health activities, it is also a clear endorsement of our innovative AtomoRapid™ technology as a preferred solution for rapid diagnostic testing.”

AtomoRapid™ HIV for professional use was launched in early 2014 and has demonstrated high rates of user preference over existing RDT kits in the field. It has also won a number of prestigious international awards, including ‘Best in Show’ at the 2014 Medical Design Excellence Awards.

Dr. Linda-Gail Bekker, Executive Director of the Desmond Tutu HIV Foundation and President of the International AIDS Society said, “Young South Africans surveyed at the Foundation’s mobile and youth clinics preferred self-testing with the Atomo product over traditional HIV test kits.  We urgently need innovation that will facilitate the UNAIDS ambitious goal of 90% of all HIV positive people knowing their status by 2020. GHIF’s investment in Atomo has laid a foundation towards that 90% goal through HIV self-testing.”

As well as supporting tests for HIV, malaria and Ebola, Atomo is finalizing development of an AtomoRapid™ Hepatitis C test on the platform. The company is currently also refining a combination test platform that can diagnose multiple diseases at once, as well as solutions with digital readers and e-health capabilities.

About the Global Health Investment Fund:

GHIF is a private investment fund structured by JPMorgan Chase & Co. and the Bill & Melinda Gates Foundation.  The fund received anchor support from Grand Challenges Canada (funded by the Government of Canada), the German Ministry for Economic Cooperation and Development (acting through KfW), the Swedish International Development Cooperation Agency and the Children’s Investment Fund Foundation. The fund’s limited partners also include AXA, GlaxoSmithKline, International Finance Corporation, JPMorgan Chase & Co., Merck, Pfizer Foundation, Storebrand and individual investors.

The fund finances late-stage therapeutics, vaccines and diagnostics for diseases that disproportionately affect low-income populations.  Key global health challenges targeted by the fund include malaria, tuberculosis, HIV/AIDS, cholera, maternal and infant mortality and other neglected infectious diseases.  The fund and its sponsors believe it offers a novel opportunity to bring about significant improvements in the treatment and prevention of diseases, and reductions in child and maternal mortality, along with the prospect for positive financial returns.

About Atomo Diagnostics:

Atomo is a leading innovator within the point-of-care diagnostic industry, focusing on disruptive solutions that improve usability, safety and accuracy of rapid diagnostic tests (RDTs). The AtomoRapid™ platform supports a wide range of clinical applications and the company is currently commercializing solutions for detection of serious infectious diseases, wellness markers and screening tests for chronic conditions.

Atomo also supplies its platform technologies as an OEM solution, to global diagnostic partners seeking to better meet the needs of their users and enter consumer self-test markets.

Desmond Tutu HIV Foundation Successfully Complete Study on Atomo HIV Self Test

Cape Town, South Africa

The Desmond Tutu HIV Foundation has successfully completed an acceptability and usability study on HIV self-testing using the Atomo HIV Self Test. With 224 participants enrolled, the study provides valuable information into one potential avenue to rapidly expand HIV testing services, which is the gateway to HIV prevention.

The participants were self-enrolling adolescents and young adults, of which 20% had not had an HIV test done before and therefore a self-test was their first experience. After receiving some product familiarisation, 96.4% of the participants were able to successfully complete the self-test and correctly read and interpret their results. With the remaining 3.6% who failed the first time, all eight of them were able to successfully complete the test on the second turn and were aware that they had failed to complete the first time. This resulted in a high level of satisfaction, with users rating the Atomo HIV Self Test a 4 out of 5 for usability and a 4.2 out of 5 for acceptability.

“These results are extremely encouraging to see and shows us that feasible and usable complementary options exist to traditional HCT [HIV counselling and testing] facilities based testing,” said Professor Linda-Gail Bekker, Chief Operating Officer of the Desmond Tutu HIV Foundation. “In order to meet the UN’s 90-90-90 Goals, a serious scale up of testing is going to need to take place and the Desmond Tutu HIV Foundation believes that HIV self-testing can support this.”

Atomo Diagnostics and the Desmond Tutu HIV Foundation will continue to work together to conduct additional research and ensure that a high quality self-test is being brought to market.

John Kelly, CEO of Atomo Diagnostics said “the results of this study are proof that through our collaborative commercialisation approach, Atomo is designing products that meet the needs of our users and allow our partners to expand testing programs where it is most needed. Since completion of this study, further optimisation of our self-test solution has taken place and will be ready for the market in 2016.”
About Atomo Diagnostics www.atomodiagnostics.com

Atomo Diagnostics is an award-winning Australian based healthcare company that develops and commercialises next generation solutions addressing unmet user needs in the diagnostic industry.

About the Desmond Tutu HIV Foundation www.desmondtutuhivfoundation.org.za
The Desmond Tutu HIV Foundation is a multi-award winning organisation in pursuit of excellence in research, training, prevention and treatment of HIV and related diseases in South Africa.

To view the full article, please click here

Spotlight Reporting Appoints David New as Director of Strategic Relationships

Spotlight Reporting have appointed Sydney-based David New as our Director of Strategic Relationships.  David comes to us with an impressive track record in software, from an MD role at Attache, National Sales Director at Xero and most recently as Country Manager, Australia and New Zealand at Receipt Bank.

ABOUT SPOTLIGHT REPORTING

Spotlight Reporting is an innovative SaaS business intelligence reporting company. Our family of four products import data from leading financial and non-financial software applications to automatically create powerful management reports, dashboards, forecasts and multi entity reporting – saving time and effort while also delivering insight and clarity for accountants and business owners. The world’s largest accounting brands use our software, as do thousands of organisations across 40 countries.

Yale Hematolgy Leader Joins Prescient Therapeutics Scientific Advisory Board

14th January 2016, ASX Announcement

Clinical stage oncology company Prescient Therapeutics Ltd (PTX) has appointed a highly respected US-based specialist in myeloid malignancies Dr Thomas Prebet MD, PhD of Yale Cancer Center to the PTX Scientific Advisory Board (SAB).

Dr Prebet is the Assistant Director of Myeloid Malignancy Research at Yale, where he is looking to expand the clinical and translational research program in myeloid malignancies.

Dr Prebet was previously with the Insitiut Paoli-Calmettes in Marseille France where he was an Associate Professor of Clinical Hematology and a member of the molecular pharmacology group, as well as the early phase trial group and coordiniator of the leukemia ward.

 To read the full announcement, please click here.  

Altech Appoints HPA Sales & Marketing Manager

14th January 2016, ASX Announcement

Altech Chemicals Limited (Altech/the Company) is pleased to announce the appointment of Mr Martin Ma as the Company’s sales and marketing manager (China). This key appointment marks an important step as the Company progresses its marketing strategy for the high purity alumina (HPA) project specifically for the Asia Pacific region. The appointment follows the previous announcement regarding Altech’s sales and distribution agreement with Mitsubishi Corporation on 24 September 2015. The agreement appoints Mitsubishi as the exclusive seller and distributor of Altech’s final HPA product to the Japanese market.

Mr Ma is highly experienced in sales management of high purity feedstock materials to Chinese industries such as the lithium battery and electrical vehicle industries. Mr Ma is a chemistry engineering graduate from the Henan University Chemistry Institute in China. His background in lithium battery separators and electrolyte technology, which are fast-growing markets for HPA, will be invaluable for the Company’s future HPA sales and distribution.

To read the full announcement, please click here

Biotech Acquires Bioatrix

In December 2015, US company ZZ Biotech LLC completed the acquisition of Bioatrix Pty Ltd. Based in Houston, ZZ Biotech is in a Phase 2 trial with 3K3A-Activated Protein C (‘3K3A-APC’) in acute ischemic stroke patients, supported by a grant from the National Institute for Neurological Disease and Stroke.  ZZ Biotech’s Australian subsidiary is presently manufacturing 3K3A-APC at Patheon Biologics in Brisbane and it has secured Queensland Government grant funding to facilitate the manufacture.  The Australian subsidiary will pursue a Phase 2 trial with 3K3A-APC in chronic wounds in 2016, and ZZ Biotech will undertake further trials of 3K3A-APC in stroke.

 

Atomo Diagnostics Secures US$6M from Global Health Investment Fund Backed by Bill Gates

14th January 2016, Sydney Morning Herald by John McDuling

An investment fund backed by billionaire Bill Gates is pouring $6 million into a Sydney HIV and malaria testing company.

The US based Global Health Investment Fund (GHIF), which was set up by the Bill and Melinda Gates Foundation and investment bank JPMorgan in 2013, will hand Sydney based Atomo Diagnostics fresh funds as it seeks to scale up production of its self testing devices, expand its sales activities and the commercial rollout of its products in developing countries.

Atomo makes a palm-sized device that makes it possible for people to test for HIV in their own home, and has already been exporting devices to South Africa.

The diagnostic testing industry shot to prominence in the investment world for all the wrong reasons last year. Theranos, a Silicon Valley startup valued at $US9 billion, which claims to have the technology to carry out comprehensive testing for hundreds of conditions using a few drops of blood from a finger prick, much more cheaply than existing methods, was accused of “struggling” with its blood tests, and actually testing people using traditional machines.

Yet Mr Kelly said the increased scrutiny surrounding Theranos could actually benefit his company. “It has put a commercial value on companies that have disruptive diagnostics,” he said. “Although they have failed to execute, they [Theranos] have opened up that opportunity in the eyes of investors, and that’s what we hope to capitalise on.”

The investment will be structured as a loan with warrants attached to it, he said. Atomo, which was established five years ago, also secured a $1.8 million grant from the NSW Government last year. It will now attempt to raise an additional $6 million in equity from investors, which could include GHIF.

To read the full story, please click here

DomaCom Raises $8m – Pre-IPO Fundraising Round Closing Soon!

DomaCom Ltd, an Australian company which has developed the first and only Regulated Fractional Property Investment platform in the country, have raised $8m cash in their pre-IPO fundraising round which is due to close Friday January 15, 2016

The raising will allow DomaCom to proceed to IPO and fund its operation to break even.

The raise was managed by Axstra Capital, a Sydney based Corporate Advisory Firm and led by corporate advisor Daniel Coombes.

“We are very pleased with the result and to be able to close the pre-IPO ahead of schedule,” he said. “The strong support received from investors is testament to the potential of DomaCom and the truly innovative pipeline of financial products it has developed. With this funding in place, the company can now focus its attention on the next step of listing on the ASX.”

The key objective of DomaCom is to provide a solution to the investment markets’ need for access to direct and specific property exposure through relatively small transactions with an initial focus on the Self-Managed Super Fund (SMSF) market. It does this by enabling investors to purchase “fractional interests” in specific properties of their choosing using DomaComs unique managed fund legal structure and online platform.

These fractional interests give investors exposure to an income stream and capital growth (or loss) of the underlying properties in direct proportion to the fractional interest purchased.

Over 30 financial planning dealer groups’ investment committees have agreed to put the DomaCom Fund on their approved product lists and DomaCom is gaining traction.

“We have already acquired our first 10 properties with another 57 property acquisitions in progress via adviser managed book builds which should take our total properties on the platform to nearly 70 properties with a market valuation in the order of $40 Million” says CEO Arthur Naoumidis.

Underlining the scale of property purchase that is possible through DomaCom, it recently launched a $410m crowd-funding campaign to purchase S Kidman & Co., Australia’s largest landholding. The pitch targets those keen for the Kidman Station to stay Australian-owned and registrations of interest from investors of over $30m have already been received.

Read more here.

KEY PRE-IPO HIGHLIGHTS:

  • A total of A$8M has been raised to date from sophisticated and professional investors including a $2.5m investment from ASX listed Fund Manager Contango Asset Management
  • Pre-IPO share price is $0.50 AUD
  • DomaCom Ltd has over 140 shareholders

FURTHER INFORMATION:

Sophisticated investors interested in purchasing shares prior to the current offer closing on Friday 16th January can contact Daniel Coombes from Axstra Capital on (02) 8234 4409 or email daniel@axstra.com.au.

 

ABOUT DOMACOM:

www.domacom.com.au

DomaCom Australia Limited is the operator of an investment platform offered through an ASIC regulated Managed Investment Scheme, the DomaCom Fund.

The DomaCom Fund enables investors to select properties of their choice in which they would like to invest. Via a book build process, investors can commit as much as they want towards the eventual purchase of the property/ies of their choice together with other like-minded investors. DomaCom has appointed Perpetual Trust Services Ltd to be the Responsible Entity and Perpetual Corporate Trust Ltd as the Custodian for the Fund. Perpetual holds the title for each property.

Ultimately, investors can select any Australian properties to invest in from residential, commercial, rural, retail, industrial and resort/leisure property lists.

ABOUT AXSTRA CAPITAL:

www.axstra.com.au

Axstra Capital is a Sydney-based Corporate Finance firm that specialises in capital raisings and corporate transactions for private and small cap ASX listed companies. Axstra Capital holds an AFSL No 390786.

Crowd Mobile Expands Presence in Asia

12th January 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) is pleased to announce it has executed agreements to launch into Asian countries India, Philippines, Thailand and Indonesia, as the Company  continues its global expansion strategy.

Commenting on the Asia launch, Crowd Mobile CEO Mr Domenic Carosa said:

“Our expansion in Asia marks a new phase of growth for Crowd Mobile. The region represents a really exciting growth opportunity with the emergence of smartphone usage. Mobile phone penetration in Asia is at around 40% currently and by 2019 is expected to be at around 52%. It is projected that there were approximately 2.5 billion mobile phone users in the region in 2015.

“We expect Crowd Mobile to have a strong disruptive effect in Asia. Our m-payments system is particularly suited to this market as a lot of Asia simply does not have credit cards. Currently, around 60% of internet users in the region are aged between 15 and 34 years which is a great fir for our innovative products. We are continuing to build our m-payments network, launching new and innovative products, and building a larger and more engaged customer base”, Mr Carosa.

To read the full announcement, please click here.

Exclusive: For the First time, Audience Demand Data for Digital Original Series Around the World

For the first time ever, Parrot Analytics releases an intelligence report detailing the demand for twenty OTT- exclusive titles in ten global markets. This type of analysis is the first of its kind in the industry, as traditional measures of popularity rely on access to viewership numbers that OTT platforms keep close to their chests.

Get the report here.

Here, we present a small sample of the data and analysis available in this intelligence report: the demand for four digital original titles from July 2015 to November 2015 in the United Kingdom. From these shows, we observe four different patterns in their demand.

To get unprecedented insights into demand for digital originals in other global markets, such as Australia, France, Mexico and Russia, be the first to get access to the industry’s first Digital Originals Intelligence Report here.

 

Prescient Therapeutics to Present at Biotech Showcase 2016 in San Francisco

11th January 2016, ASX Announcement

Clinical stage oncology company, Prescient Therapeutics Ltd (ASX:PTX) advises that it will be presenting at the Annual Biotech Showcase is San Francisco, USA this week. Biotech Showcase is a respected investor and networking conference devoted to providing private and public biotechnology and life sciences companies will an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences.

To view the full announcement, please click here

BioDiem Annual Update 2015; WHO Prequalification & Commencement of Royalties

BioDiem’s commercial position improved significantly during 2015 with commencement of royalties from the sale of Nasovac-S™ in India, and the achievement of WHO prequalification: a necessary certification to allow export to other countries. Additionally, BioDiem’s Chinese licencee, the Changchun BCHT Biotechnology Company received approval from the Chinese FDA to conduct clinical trials – an important milestone in the development of BCHT’s LAIV vaccine.  BioDiem’s subsidiary, Opal Biosciences’ fund-raising was launched to develop its novel antimicrobial to target difficult-to-treat and resistant infections. New treatments are needed due to reports of increasing antibiotic resistance.

ABOUT BIODIEM

With rising concern about viral infections, “superbugs” and antibiotic resistance, BioDiem is well-positioned with its focus on commercialisation of infectious disease therapies and vaccines. An established ‘flu vaccine licencing business is drawing revenue from commercial partners in India and China. Nasovac-S™ is marketed in India and has recently received WHO prequalification which allows export to new markets. New anti-infectives are needed due to increasing resistance to existing antibiotics, more difficult-to-treat infections, and paucity new treatments. BioDiem’s subsidiary, Opal Biosciences Ltd is an innovative player in infectious disease treatment, targeting human infection – a high growth, commercially attractive market segment.

FDA Allows Prescient IND for Leukemia Phase Ib & II Trials

8th January 2016, ASX Announcement

Highlights:

  • PTX has four FDA approved INDs demonstrating the strength of its cancer treatment assets
  • Follows Phase I study that demonstrated 17 out of 32 patients achieved disease stabilization. These were patients with advanced leukemia with few remaining treatment options

Clinical stage oncology company Prescient Therapeutics Ltd (PTX) has secured US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) application for the forthcoming Phase Ib and Phase II clinical trial and program in acute myeloid leukemia (AML).

The study will combine PTX’s lead drug candidate, the novel AKT inhibitor PTX-200, together with the chemotherapeutic agent cytarabine, in refractory or relapsed patients with AML.

The Phase Ib and Phase II studies will be lead by hematologist Professor Jeffrey Lancet at the Moffitt Cancer Center and Research Institute (Moffit) in Tampa, FL USA.

To read the full announcement, please click here

iFAST Completes Proposed Acquisition of Stockbroking Firm

7th January 2016, iFAST Corporation

The Board of Directors of iFAST Corporation  Ltd. (“the Company”, or together with its subsidiaries, the “Group”) refers to the announcement released by the Company on 10 June 2015 and 2 December 2015 relating to the Agreement for the Sale and Purchase of the entire share capital of the Winfield Securities Limited (“Winfield Securities”) representing 100,000 shares of HK$1.00 each in the issued and paid-up share capital of Winfield Securities (“Proposed Acquisition”) and receipt of approval from the Securities and Futures Commission of Hong Kong (“SFC”).

The Company is pleased to announce that the Proposed Acquisition has been completed on 6 January 2016 with the purchase consideration revised from the estimated HK$14.7 million to HK$15.8 million after reviewing the Updated Management Accounts of Winfield Securities at completion date.

To read the full announcement, please click here.  

BIG Sponsorship Agreement with Fashion Brand Mojo Downunder

7th January 2015, ASX Announcement

Highlights:

  • Australian fashion brand, Mojo Downunder has entered into a sponsorship agreement with Big Review TV Ltd (BRTV)
  • Sponsorship agreement will provide Mojo Downunder with pre-roll advertising slots in selected Big Review TV video content featuring luxury or fashion brands
  • Sponsorship agreement represents the first foray by an advertiser into Big Review TV retail fashion sector content
  • Activation of further revenue from advertising opportunities in vertical markets

Big Un Limited  (ASX:BIG, or ‘the Company’) is pleased to announce a sponsorship agreement with Mojo Downunder. The agreement with Mojo Downunder includes pre-roll advertising and integration of sponsored BIG content in social media.

Mojo Downunder Ltd is an Australian company founded in 2003 producing luxury fashion items aimed at a global menswear market.

To read the full announcement, please click here.  

Leanne Graham Appointed to BIG Advisory Board

22nd December 2015, ASX Announcement

Highlights:

  • Former Xero Executive and technology entrepreneur, Leanne Graham to join BIG Unlimited’s Advisory Board, effective 22 Dec 2015
  • Ms Graham has a track record of leading successful technology businesses and delivering significant growth across early stage businesses
  • The appointment of Leanne Graham brings access to a significant network of global contacts to accelerate BIG’s B2B expansion
  •  High calibre appointment strengthens an existing strong Advisory Board underpinned by three experienced Google executives
  • Strong leadership in place to execute and drive BRTV’s international expansion

Big Un Limited (ASX:BIG, ‘BRTV’ or ‘the Company’) is pleased to announce the appointment of Ms Leanne Graham to its Advisory Board, effective 22 December 2015.

Ms Graham brings over 28 years’ experience within the software and technology sector. Her expertise gained within the Software as a Service (SaaS) sector are second to none and highly respected. As a General Manager and Global Head of Sales at Xero, Ms Graham succesfully led the sales strategy and during her three years tenure the customer base increased by 500% from 4,000 to over 12,000 enterprise and SME customers.

To read the full announcement, please click here

Tesserent Ltd to Close IPO Early Due to Strong Demand

As you may be aware, Tesserent Limited is proposing to list on the ASX, with an offer to subscribe for shares now open.  The proposed closing date for the offer is 05 February 2016 but, due to strong demand, it is anticipated that the offer will close earlier than the originally planned date.  Accordingly, if you are planning to subscribe for shares, we would advise you to do so now.

To register your interest in the offer, please click on the button below.

ABOUT TESSERENT 

The Company provides Internet security services to help organisations defend against cybercrime. Tesserent has developed a security infrastructure platform, known as the MSSP Platform, which enables delivery of Security-as-a-Service (‘SECaaS’) on a subscription basis to small and large organisations to protect their computer networks.

Tesserent directly provides Security-as-a-Service to customers in Australia and internationally, and has also appointed Channel Partners in Hong Kong, South Korea, United Kingdom, and the UAE, who in turn use the MSSP Platform to provide Security-as-a-Service to their own customer bases. Gartner forecasts the SECaaS market will grow to US$27 billion per year within the next four years.

BioDiem Fund-Raising Update January 2016

Announcement: BioDiem Fund-raising update

  • placement to two major shareholders in September 2015 ($298,820)
  • rights issue and additional commitment from major shareholders ($289,373) 

R&D Tax Incentive rebate

  • received $215,707

Licence fee for LAIV

  • received US$84,197

Shortfall available for allocation: $158K,025 (1,975,316 shares)

To request shortfall application form email us here.

For more information, please click here.

iFAST Announce Appointment Of Executive Director

30th December 2015, iFAST

The Board of Directors of iFAST Corporation Ltd. ( the Company ) is pleased to announce the appointment of Mr Kelvin Yip Hok Yin as Executive Director of the Company with effect from 1 January 2016.

Details of Mr Kelvin Yip Hok Yin as required under Rule 704(7) of the Listing Manual of the Singapore Exchange Securities Trading Limited are set out below.

Please refer to Appendix A for information on the composition of the Board of Directors and Board Committees effective 1 January 2016.

To read more, please click here

DomaCom Ltd Annual Update 2015; Wins ‘Most Disruptive’ Award and Raises Over $5.5m for Pre-IPO Round

2015 Highlights:

  • Launched a $410m crowdfunding campaign for Kidman Station, the country’s largest landholder; Raised more than $30m last months
  • Partners with Shaw and Partners corporate advisory
  • Wins ‘Most Disruptive’ Award
  • Raised over $5.5m for its Pre-IPO Round
  • Partners with Shaw and Partners corporate advisory

ABOUT DOMACOM:

DomaCom Ltd is the first and only regulated Fractional Property System in the country. Through the DomaCom fund, self-managed super funds can purchase fractions of any property type. They can also trade their interest in a particular property on a secondary market without having to sell the property.

DomaCom is not a concept. It’s a proven business with a number of property settlements completed and a further $60m in the pipeline. They have over 600 financial planners approved to use their platform.

Folkestone Ltd (ASX:FLK) Annual Update 2015; Raised $42m & Reported a 122.6% NPAT Increase

2015 Highlights:

  • Net profit after tax of $7.0 million, up 122.6% on FY14
  • Funds under management of $917 million, up 12.8% on FY14
  • Successfully raised $42 million from a Placement and Entitlement offer
  • Launched the Folkestone Truganina Development Fund
  • Folkestone entered into a JV with the Lyon Group Australia, a leading Sydney property developer, to acquire a site in Sydney’s North-West
  • Launches two new developments
  • Voted Best Performing A-REIT Manager For FY15 by Morningstar Australian Institutional Sector Survey

ABOUT FOLKESTONE:

Folkestone is an ASX listed real estate funds manager and developer which offers listed and unlisted funds to investors. The Company generated a net profit after tax of $7.1m in FY15, an increase of 122.6%, recorded strong growth of more than of 12.8% to $917m FUM and a development pipeline in excess of $1.0bn.

Folkestone manages the Folkestone Maxim A-REIT Securities Fund a high conviction, actively managed fund that gives investors exposure to a mix of quality listed A-REITs that own assets across the retail, residential, commercial, hotel, industrial and real estate related social infrastructure sectors. The Folkestone Maxim A-REIT Securities Fund was the best performing fund in the Morningstar Australian Institutional Sector Survey in FY15.

YuuZoo Corporation Ltd (SGX:AFC) Annual Update 2015; Secures SG$30m From GEM Global & Reports a 93% Revenue Growth

2015 Highlights:

  • Secures SG$30 million Capital Commitment from GEM Global
  • Signs Exclusive Partnership Agreement With JW Lottedi in China
  • Strenghtens Board With Appointment Of International Investor & Venture Capitalist
  • Forms E-Sport Joint Venture in China
  • Buys Key Assets From Leading Chinese Mobile Game Developer
  • Acquires Distribution and Marketing Rights for Mobile Games
  • Reported a revenue growth of 93% to S$ 42.6 Million

ABOUT YUUZOO

Yuuzoo (SGX:AFC) is a Singaporean listed company that combines social networking and e-commerce in a mobile-optimized, fully localized virtual shopping mall, where the consumer can access hundreds of targeted social networks, targeted shops and targeted entertainment through one single login.

The Company builds mobile-optimised and device agnostic targeted social e-commerce networks for businesses and consumers, either rolling them out on their own (“Yuu-Branded Networks”) or together with businesses or brands (“Client Branded Networks”).

CEO and Chairman Thomas Zilliacus, is a well-recognised innovator and leader in the mobile business space having spent a significant number of years working in senior management positions with global industry leaders.

Big Review TV Ltd (ASX:BIG) Annual Update 2015; Raises 3m & Reports 164% Revenue Growth

2015 Highlights:

  • Successful completion of $3 million capital raise, significantly oversubscribed with strong interest from existing and new investors
  • Revenue currently growing at 50% quarter on quarter with the last quarter generating over $400k in revenue
  • Reported cash revenues growth of 164% on Q1 2015
  • Signs partnership agreement with CDM Direct Communication Services & First Class Capital
  • Operations expanded into the U.K., U.S., Hong Kong and Singapore

ABOUT BIG REVIEW TV:

Founded in 2012, Big Review TV is an ASX-listed global, social, mobile video community that provides small and medium businesses access to affordable video marketing and consumers with the opportunity to view and share opinions and reviews via video.

Big Review TV is the first operator to integrate businesses and consumers via a video community. BIG has over 6000 business registered and has begun expansion into the UK and US from their base in Australia.

DeClout Ltd Annual Update 2015; 165% Revenue Increase

2015 Highlights:

  • Reported a 165% increase in revenue year-on-year to a record $ 121 million for 1H2015
  • DeClout’s Corous360 launched PLAYe a 3-in- 1 online-mobile-offline platform
  • Revived the Pacific Internet Brand; Acquires ISP business from Telstra

ABOUT  DECLOUT:

Led by a dynamic team of IT veterans, DeClout aims to be the leader in next generation technology driven services in Asia, delivering innovative and cost-effective solutions that will make us the partner of choice for leading companies across the region. Listed on the Catalist Board of the Singapore Exchange in 2012, the Group operates two core business segments – IT Infrastructure Services and Vertical Domain Clouds (VDCs) – out of Singapore, Malaysia, Indonesia, Thailand, Myanmar, Cambodia, the Philippines, China, the United States and United Kingdom.

Drawing on the expertise and synergies gained from our array of complementary IT Infrastructure Services, the Group is capitalising on exciting opportunities through our VDCs – vibrant, self-contained and scalable ecosystems or communities – starting with the online games and e-commerce industries. Our vision is to create diverse VDCs that serve the needs and aspirations of different businesses and user communities.

YPB Group Ltd (ASX:YPB) Annual Update 2015; Raises $7.78m & Executes Multiple Partnership Agreements

2015 Highlights:

  • Raised $7.78m for acquisition and growth
  • Commenced Supply of Anti-Counterfeit Solution to 2 Chinese National Banks
  • YPB’s VariSec technology to be applied to 16.5 million ePassports
  • Acquired nTouch and signed MoU to acquire Motif Micro Inc
  • Selected to protect the entry permit of staff for Beijing’s Palace Museum

ABOUT YPB GROUP:

YPB was listed on the ASX in August 2014. YPB’s shares at IPO were .20c.

YPB means “Excellent Brand Protection” in Chinese. By 2015 the Global Counterfeit market will be US$1.7 Trillion, and US$14bn (growing at 20% pa) will be spent on Anti-counterfeit technologies per annum in Asia. YPB is the only Company licensed by CTAAC in China that sells invisible tracer solutions.

YPB’s patented tracer is Invisible, Indestructible and Inexpensive and our recurring revenue model generates up to 90% gross margin on sales.

Since IPO, YPB has signed significant revenue contracts, has acquired a USA based business named ‘Brand Reporter”, has amassed to date 7 Patents, has established distribution in China, Thailand, Indonesia, India, Australia and USA.

MedAdvisor International Pty Ltd (ASX:MDR) Annual Update 2015; Lists on the ASX & Establishes Important Partnerships

2015 Highlights:

  • Raises $5m in oversubscribed public offer
  • Commences trading on the ASX under ticker code MDR
  • Announces new medication training relationship with Amgen
  • Share price up 90% since listing
  • Established important partnerships with pharmaceutical companies GSK, UCB, AstraZeneca and Apotex, as well as private health insurer, BUPA
  • One quarter of Australian pharmacies subscribed to the MedAdvisor platform

ABOUT MEDADVISOR INTERNATIONAL:

MedAdvisor International Pty Ltd is an Australian medical technology business focused on designing and commercialising world class software platforms for medication management on mobile and internet devices. MedAdvisor’s Platform connects to pharmacy dispensing systems, automatically retrieving medication records and driving an intelligent training, information and reminder system to ensure correct and reliable medication use.

MedAdvisor has established strategic partnerships with Bupa Australia and most recently, distribution partner Apotex Australia. The company is also supported by Australia’s major pharmacies including Amcal, Chemmart, Terry White Chemists, Guardian Pharmacy and more.

Oncosil Medical Group (ASX:OSL) Annual Update 2015; Shares Up Over 182%

2015 Highlights:

  • Share price up 182.35%
  • Completed the granted Fast Track review by the European regulator Conformité Européenne
  • International life sciences research group, Van Leeuwenhoeck Institute, initiated an analyst research coverage on the Company
  • Multiple new Board Appointments

ABOUT ONCOSIL MEDICAL GROUP:

OncoSil™ is a patent protected proprietary medical device (class III) that creates a localised stream of beta radiation. The product is created by melting up to 5% phosphorous in liquid silicon in a furnace which is then shattered into small particles using sterile water. The resulting radioactive phosphorous (P32) produces radioactive beta particles that can be emitted for up to three months.

Patients with unresectable pancreatic cancer have few treatment options. The current standard of care is to provide intravenous chemotherapy, and in some cases external beam radiation. The OncoSil™ is intended to complement existing standard of care chemotherapy.

8i Ltd Annual Update 2015; Raises NZD$20m & Features in NY Times

2015 Highlights:

    • Raised NZD$20m in the last 12 months.
    • Global investors include RRE Ventures, Founders Fund Science, Horizons Ventures, Samsung Ventures, Dolby Family Ventures, Bertelsmann Digital Media Investments, Sound Ventures, Signia Venture Partners, Inevitable Ventures, Freelands and Advancit Capital, Kevin Wall, Jeremy Stoppelman, John and Andrew Hendricks, End Cue and Kortschak Investments, Rothenberg Ventures, Boost VC and Ashton Kutcher.
    • Featured in the New York Times Business Section

ABOUT 8I 

8i breaks the main barriers to creating compelling 3D media content at scale — quality, time and cost. 8i holographic is a groundbreaking system for recording video and translating it into highly realistic, genuinely 3D digital content. The process is dramatically faster and an order of magnitude less expensive than computer animation.

8i is strongly positioned to meet growing demand for content for virtual reality (VR) display devices like the Oculus Rift. 8i holographic content can also be viewed on other 3D displays and conventional 2D computer monitors. We will commence production of 8i holographic content for clients by Jan 2015 and aim to release our software and distribution products in 2016. 8i team features Academy, Emmy and Edison Award-winning talent with decades of experience at the world’s leading studios.

DomaCom Engages Shaw and Partners to Assist Kidman Crowdfunding

Monday December 21, 2015

Arthur Naoumidis, CEO of crowd-funder DomaCom, today announced a partnership with Shaw and Partners corporate advisory to assist DomaCom split the Kidman group of properties from the operating business if DomaCom successfully acquires the land.

S. Kidman and Company came to market several months ago and was acquired by Chinese interests in October. But the sale was blocked by the Foreign Investment Review Board (FIRB).

At the request of financial adviser and pastoralist, Stephen Burgin, DomaCom stepped in to create a book-build for Australian investors, several hundred of whom have since lodged expressions of interest to participate in the acquisition.

As DomaCom is only interested in the land, an operator is being sought to manage the business, stock, plant and equipment, and Shaw and Partners has agreed to provide advice about how to achieve the best outcome for a new Kidman operating entity. This could involve an IPO, a joint venture with a listed company or a separate transaction.

Naoumidis said: “Kidman management appears to be looking at breaking up the holding to overcome FIRB’s concerns, but we think there is a better solution in splitting the property from the operational business.

“Anyone taking on management of the business would more likely prefer to invest their capital in the business than the land, which is why we have engaged Shaw and Partners to investigate this option.”

Earl Evans, Head of Wealth Management at Shaw and Partners, added: “We believe the DomaCom crowd-investing model is a very workable solution and that we can add value to the Kidman group with an alternative structure that can potentially deliver a more profitable outcome.

To download the full document, please on the link below. 

DomaCom Gets Shaw and Partners on Board for Kidman Station Crowdfunding Campaign

20th December 2015, Sydney Morning Herald By Sally Rose

Investors have put their hands up for more than $30 million in the first 10 days of a crowdfunding campaign that aims to raise up to $410 million to buy Australia’s largest landholder, S. Kidman & Co.

Now DomaCom, the company running the offer, is pitching it to industry superannuation funds in the hope of reaching their target before the cattle station operator is sold to a consortium of Chinese-government-backed bidders.

“We have had a great response from self-managed super fund investors and are now also in talks to pitch the offer to a number of industry super funds,” DomaCom chief executive Arthur Naoumidis said.

S. Kidman & Co owns more than a dozen cattle properties, covering 101,000 square kilometres – 2.5 per cent of the nation’s agricultural land.

Last month, Treasurer Scott Morrison blocked the sale of the business to a consortium of Chinese bidders, for $360 million to $370 million, on the ground that it would be against the national interest. The group’s Anna Creek Station in South Australia is considered strategically important because it borders the secret military testing area at Woomera.

A revised offer from the Chinese bidders is expected.

Self-described “fractional property investing platform” DomaCom, with the backing of a network of independent financial planning groups, launched its campaign to assemble a counter offer.

“In the first 10 days more than 600 people have registered their interest to participate, with total indicative contributions topping $30 million,” Mr Naoumidis said.

“Three people have registered interest for up to $1 million, and a handful of others have indicated they might buy more than $250,000 worth of shares”.

To read the full article, please click here

Crowd Mobile Annual Update 2015; Revenue up 32% and 5 New Apps Launched

  • Reported a revenue of $13.0 million, up 32% year-on-year
  • Recently launched services into Baltics, Balkans and South Africa
  • Launched 5 new apps
  • Signed a share purchase agreement for Track Concepts Acquisition
  • Share price has increased over 50% in the last 6 months

ABOUT CROWD MOBILE 

Crowd Mobile is a global m-Content, m-Payments, m-Commerce, mobile entertainment and micro job company that allows customers globally to crowd source answers to their much-needed questions and pay a small fee for each answer received. Crowd Mobile operates in 40 countries and answers in 28 languages. Crowd Mobile answered more than 5.7 million questions in FY15.

 

AirService Annual Update 2015; Raised $1.5m; Signed on Multiple New Clients

We successfully raised our first round of capital, $1.5million, which will largely go towards expanding our Australian footprint.

AirService is now providing branded mobile ordering solutions for GPT Group, Lend Lease and Jones Lang LaSalle, with the newly formed Vicinity Centres scheduled for the new year.

Former Wallabies captain George Gregan has joined the AirService family, with his Gregan Group coming onboard as a client with their 25+ venues around Australia.

After dissatisfaction with their current mobile ordering solution, the Sydney Cricket & Sports Ground Trust turned to AirService and have brought the SCG and Allianz Stadium on board.

Village Roadshow is shaping up as a major AirService client, with selected cinemas and now Village Roadshow Theme Parks (Warner Bros. Movie World, Sea World, Wet’n’Wild Water World).

AirService has been confirmed as providing the app and mobile ordering solution for Roadchef in the UK. Roadchef operates 30 roadside service areas across Britain, and has over 44million customer visits per year.

We’re anticipating that the integration of AirService with other complementary tech platforms will be big in 2016, and we’ve kicked that off with integration deals with Sherpa, LOKE and MSL Solutions.

Our promotions platform was successfully launched, providing our clients with another way to interact with and add value to their customers.

ABOUT AIRSERVICE 

AirService is a holistic mobile ordering and payments platform, with a focus on the in-venue experience for hotels (room service), resorts (pool-side delivery), stadiums & arenas (in-seat delivery and/or express lanes with no queues), shopping centres (express lanes for food courts) and office buildings (direct-to-desk delivery).

Catcha Group Partner Bulletin – January 2016

4th January 2016

TM-iflix collaboration = thousands of TV shows and movies!
The Star
KUALA LUMPUR: Here’s good news to end the working week. If you are a subscriber to either Unifi or Streamyx broadband service, you will be able to enjoy hours of TV shows and movies via iflix at no additional cost courtesy of Telekom Malaysia Berhad (TM).
From mid-December, all TM Unifi and select Streamyx customers will receive a 12-,month iflix subscription (valued at RM96) bundled with their existing service.

Read more

Smart and PLDT subscribers to Receive Gift of Entertainment
Teknogadyet
MANILA: iflix, the leading over-the-top content provider in Southeast Asia, will be giving Smart Communications and Philippine Long Distance Telephone Company subscribers the gift of entertainment this holiday season, wherein they will be able to access tens of thousands of hours of movie and TV shows.

Read more

IN THE NEWS

iflix crosses 1mil-subscriber mark, appoints special advisor
Digital News Asia ·  Read More

iflix partners with Telekom Malaysia to offer Internet TV service 
Rakyat Post ·  Read More

TM Unifi & Streamyx Customers to Receive iflix Subscriptions for 1-year
Low Yat ·  Read More

iflix, PLDT and Smart Share the Gift of Entertainment
Manila Bulletin ·  Read More

Smart & PLDT users get iflix access  
Business World Online ·  Read More

PLDT and Smart users get iflix subscriptions 
Gadgets Magazine ·  Read More

PLDT to hike investment in iflix
Business Inquirer ·  Read More

More Catcha Group media coverage here.

Investors Central Annual Update 2015; Raises over $16m

In 2015, Investors Central Ltd continued to grow and raised over $16M. Our third Prospectus was launched in September 2015, offering a fixed term interest security paying rates of 9% to 16% per annum, with interest paid monthly.

Finance One Pty Ltd a 100% owned subsidiary of Investors Central Ltd lends to the automotive industry, with the loan book currently sitting at over $47M.

109 new investments were introduced following successful presentation lunches, which were held in Townsville, Brisbane, Sydney and Melbourne, during 2015.

Investors Central has paid $11.9M to investors since inception in 2010 and continues to experience strong, steady growth. Investors Central made a $1.4M NPAT as at 30 June 2015 as is on track to make its forecasted June 2016 NPAT of $1.7M.

ABOUT INVESTORS CENTRAL 

Investors Central was established to raise capital to fund the expansion of our automotive lending business, Finance One. Since 2010, Finance One has specialised in lending to an industry sector which has up to 4 million Australian’s looking for credit.

Finance One writes loans from $5,000 to $50,000 the loan book carrying value as at 30 June 2014  being $ 19.1M. The business has enjoyed steady growth and continues to grow through relationships with an expanding network of finance brokers.

Over the past four years Investors Central has delivered consistent steady growth in both revenue and profit. This has allowed us to continually attract new investors as we grow and pay them fixed interest returns from 9% to 16% through redeemable preference share issues. Full details of the available investment opportunities are outlined in our Prospectus.

Benitec Biopharma Annual Update 2015; Lists on the NASDAQ

Benitec Biopharma (ASX:BLT; NASDAQ:BNTC) is a clinical-stage, biotechnology company developing therapeutics based on its patented gene-silencing technology called ddRNAi.

Its unique therapies target specific genes, genetic disorders and infectious diseases including hepatitis C and B, wet Age-related Macular Degeneration (AMD) and Oculopharyngeal Muscular Dystrophy (OPMD). Benitec’s strategy is to develop its technology in-house, through partnerships with other biotechnology and pharma companies, as well as through out-licensing collaborations.

This year, the company has successfully listed on the NASDAQ, released positive in vitro data for its hepatitis B program and announced encouraging preliminary data from its Phase I/IIa hepatitis C clinical trial, the company’s lead program.

Benitec has a cash position, at 30 September 2015, of approximately AU$33 million. We expect to have significant advances on all of our programs in the next 12 months.

ABOUT BENITEC BIOPHARMA LIMITED

Benitec Biopharma Limited is a publicly listed (ASX:BLT) biotechnology company whose key assets are exclusive irrevocable worldwide rights to a platform technology which has the potential to permanently silence any gene associated with human diseases or conditions. Benitec Biopharma is demonstrating the efficacy and safety of this technology through collaboration with leading organisations globally.

Ai-Media Annual Update 2015; Global Growth & Positive Cash Flow

Ai-Media continued to extend its run of world-leading broadcast captioning quality outcomes, and secured contract extensions to 2020 for its major broadcast customers.

Ai-Media’s UK expansion has provided the springboard for global growth, with multiple languages now offered for both live and offline captioning for broadcast, education, corporate, and government clients. Ai-Media delivered Nesta Impact Investments its first successful financial exit in June, and the Education Endowment Foundation has provided a further grant to develop the Visible Classroom product suite, in conjunction with the University of Melbourne.

Cash flow positive, Ai-Media is planning its next capital raising in 2017.

ABOUT AI-MEDIA 

Ai-Media delivers live & offline television captioning under long term contracts for many Foxtel channels, education captioning for schools and universities, and high quality transcripts to 99.90% accuracy for government and corporate clients.

Ai-Media’s flagship technology solution, Ai-Live has proven effective in pilots supported by Commercialisation Australia for deaf students at school & university. Current clients include the NSW & Victorian education departments, & Macquarie University.

Ai-Media is raising capital to fund its UK expansion, and develop product opportunities in the wider education market.

APN Property and Generation Healthcare Management Joint Venture Update

24th December 2015, ASX Announcement

APN is pleased to Generation Healthcare REIT’s (GHC’s or the Fund’s) financial close on the $120 million Stage 2 project at Casey, the commencement of the $45 million expansion of Frankston Private Hospital and number of other positive recent fund initiatives. These transactions continue to build upon GHC’s momentum and are expected to further enhance GHC investors’ returns over time.

As previously disclosed GHC is managed via Generation Healthcare Management Pty Ltd (GHM), a joint venture between APN and GHC Management. Under the GHC management arrangements there is potential for GHM to earn performance fees should the Fund’s total return outperform the ASX300 AREIT Accumulation index (refer GHC announcement of 23 October 2014 for further details). It is APN’s practice to exclude such income from its Operating Earnings guidance until such time as these market dependent fees are determined.

To read the full announcement, please click here

Great Big Secret of the Online Economy – SmartWard

23rd December 2015, Australian Financial Review By Jacob Greber

Confined to a children’s ward as his eldest daughter suffered a four-month fight against brain cancer that took her life at the age of 19 months, Matt Darling started watching the nurses. Closely.

The 42-year-old computer-systems engineer systematically recorded how overworked hospital staff went through their shifts.

He was struck by how much of their valuable time was lost to basic paperwork – an ocean of it.

Decades of growing complexity in healthcare – as well as the need to create a paper-trail to firewall hospitals, doctors and nurses against lawsuits – have gradually turned the profession into an administrative nightmare.

Darling estimates nurses in Australia’s hospitals now spend less than one-third of their time with patients.

“The problems in hospital care are systemic ones,” he says. “A very dedicated workforce are distracted from patients by a sea of paperwork. It’s not very efficient, but that’s not the staff’s fault.”

Darling’s response – building on a career addressing information-technology headaches for the departments of defence and finance in Canberra – was to design a software system that could not only reduce the paper blizzard, but adapt to changes in care and treatments. Importantly, it had to be easy for nurses and other health professionals to use.

He founded Canberra-based company, SmartWard, which has raised more than $10 million from investors and has run trials of its system in hospitals in Victoria and Queensland, with more planned elsewhere.

To read the full story, please click here

YPB Raises $7.78m for Acquisition and Growth

22nd December 2015, ASX Announcement

Highlights:

  • YPB placement to raise A$7.78 million
  • Placement compromises a A$2.78 m placement to professional and sophisticated investors in addition to a A$5 m cornerstone investment
  • Funding to secure Motif Micro acquisition and investment for growth

Brand authentication solutions company YPB Group Limited (ASX:YPB) has secured A$7.78 million in funding through a placement to institutional, professional and sophisticated investors at 26 cents per share.

The placement includes a A$5 million investment by Lanstead Capital LP (Lanstead) by way of a placement of 19,230,769 ordinary shares at $0.26 per share, details of which include the following:

- YPB will receive A$750,000 of the investment upfront with the remainder invested in an equity sharing agreement between the two parties. Under the agreement YPB will receive 18 monthly cash settlements for the remaining A$4.25m of the investment by Lanstead Capital. This sharing agreement allows the company to secure much of the potential upside arising from the anticipated share price performance of YPB.

To read the full announcement, please click here

Conditional Sale Contracts for TSA Sales & San Remo Update from Unity Pacific

18th December 2015, ASX Announcement

Unity Pacific Limited (ASX: UPG) (Unity Pacific) announces it has entered into conditional contracts for the sale of 760² of transferable  development rights which attach to the 308 Queen Street heritage buildings  and provides information about a positive town planning development for the land at San Remo.

Sale of TSAs

Unity Pacific currently owns 1,134m² of transferable development rights known as TSAs (or transferable site areas) which attach to the 308 Queen Street heritage building.

Unity Pacific has exchanged two conditional contracts for the sale of 760² of TSAs for a total sale price of $1.23 million to $1.29 million. The 30 June 2015 book value of the contracted 760² of TSAs was $0.3 million. The contracts are subject to relevant purchasers obtaining a development approval from the Brisbane City Council for their respective residential development projects by 30 June 2016 and 30 September 2016 respectively.

To read the full announcement, please click here

Global TV Content Demand for Game of Thrones, Cancelled Shows and SVOD Series

In our holiday edition of Global TV Content Demand, we bring you exclusive insights on the demand for cancelled shows, Game of Thrones and OTT content around the world. We also share with you the most in-demand Family-themed content in Canada over the festive season.

Thank you for reading and happy holidays!

Where is the love for the cancelled shows of 2015? 

In this week’s featured insight, we analyze the global demand for 2015 cancelled show and find out where they are still in-demand and how they rank against non-cancelled shows.

Read more.

Game of Thrones demand increases after Season 6 trailer release

We track the demand for Game of Thrones before and after the Season 6 trailer release in the US, Germany and China.

Read more.

The most in-demand, binge-worthy OTT content this holiday season

We look at the demand for the most binge-worthy content on Netflix, Hulu and Amazon in the US.

Read more.

The Blacklist vs Blindspot 

Which show is more in-demand in the US, Argentina and Canada? Find out in this week’s global demand comparison of the shows.

Read more.

Top 10 Most In-Demand Family TV Shows in Canada

The holidays are all about family! And that means sharing with you the current top ten most in-demand family-themed properties in Canada. Find out who topped the list.

Read more.

In case you missed it

BBC uses Parrot Analytics to track down new audiences for Sherlock
Re/code covers how BBC have utilized Demand Rating™ to stand out in today’s TV world.
by Re/code

The Netflix vs HBO Debate
Find out how Parrot Analytics’ global content demand measurement data played a role in the recent conversation around Netflix vs HBO content as referenced in the IndependentInquisitrWIRED and the Business Insider.

How Artificial Intelligence is disrupting the Media Industry
With more data readily available, find out how Parrot Analytics are enabling much deeper audience insight.
by AI Business™

Tony Young Appointed Independent Director at APN Property

17th December 2015, ASX Announcement

APN Property Group Limited (ASX Code APD) is pleased to announce the appointment today of Mr Tony Young as an independent non-executive director to its Board.

Mr Young is a professional investor with a significant investment in APN Property Group Limited as well as a number of other real estate investments.

He is also:

  • A Director of Morningstar Australia, a leading global provider of independent fund management and equity investment research;
  • Co-owner of  Timebase Pty Limited, an Australian online law library/legal database and other services provider; and
  • Co-founder of Aspect Huntley (Australia’s leading internet equity research company and publisher of Huntleys Your Money Weekly and IFA) which was sold to Moningstar in 2006

To read the full announcement, please click here

Revolutionise Appointments in 2016 with Surga Central 3.2

Coming Soon – Surga Central 3.2 – Revolutionise Appointments and Sales Productivity

Surga Central is a next-generation software application for commercial property agencies. Find out how our new version will transform the way you sell, let and market commercial real estate.

Our next version ships in Q1 2016. Highlights include:

Calendar Appointments

Create appointments for owners, tenants and enquirers. View appointments from contact, company or property calendars.

Sync to Outlook

Sync contacts and appointments to your phone via your Microsoft Exchange/Office 365 account. As you drive to your appointment, have Siri call that important contact’s mobile number.

Break Clause Management

Receive automated break clause alerts and quickly search tenants by break clause date.

www.surgacentral.co.uk

www.surgacentral.com

www.adept.com.au

Dimerix Annual Update 2015; Lists on the ASX & Commences Phase II Clinical Study

Dimerix Bioscience has made substantial progress in a number of corporate and operational areas in 2015. In July, Dimerix Bioscience was acquired by Sun Biomedical (who subsequently changed its name to Dimerix Limited ASX:DXB). On 17th December, Dimerix announced the appointment of Dr Liz Jazwinska as a non executive director. Dr Jazwinska brings more than 25 years experience in Science and Business with Senior Roles in Industry, Academia and Government in Australia, New Zealand, UK, and Asia Pacific, including 7 years at Johnson and Johnson Research Pty Ltd.

Dimerix’s lead clinical program, a Phase II study in Chronic Kidney Disease, DMX-200, is now recruiting patients with the company aiming to provide interim data in mid 2016. Upon successful results, Dimerix intends to pursue the registration of a product for an orphan indication, and was recently granted Orphan Drug Designation for DMX-200 for Focal Segmental Glomerulosclerosis (FSGS) by the FDA.

ABOUT DIMERIX

Dimerix is an Australian biotech company developing and commercialising novel drug therapies targeted at unmet patient needs, with the lead clinical program targeting chronic kidney disease (CKD).

Dimerix conducts its laboratory operations via contracts with the University of Western Australia and the Harry Perkins Institute of Medical Research, WA. Dimerix is working with established clinical research organisations for its clinical studies.

Booodl Annual Update 2015; Raises $2.85m & Receives Best New App Award

In December 2015, Booodl completed a 2.85m strategic investment round led by Scentre Group, the owner and operator of Westfield in Australia and New Zealand. The funding will be used will be used to grow the user base and retail network.

This follows a successful pilot program in Sydney where 31,600 products were added to users’ lists, 12,500 reminder notifications were sent to nearby shoppers, and over 6,200 messages were exchanged between stores and customers.

Booodl was also featured in the ‘Best New Apps’ section of the App Store, and received two awards for ‘Best New Application’ and ‘Best Fashion Technology’.

ABOUT BOOODL

Booodl is an app that simplifies local shopping by; making it simple to list products you want to buy, locating local stores through geo-notification push reminders and location-based search, instant messaging with stores, and in-app purchasing.

The user problem/solution is validated and retail stores have embraced the value proposition. Capital is being raised to continue R&D, grow in Australia and launch internationally. Existing investors include Erica Packer, Square Peg Capital and Jungle Capital.

Charter Hall Annual Update 2015; Increases FUM to $14.8b

Charter Hall Group increased its portfolio to 290 commercial properties with $14.8 billion FUM and marked 10 year’s on the ASX.

Charter Hall Direct was rated #1 for the third year by PIR; has 4 of 10 top performing unlisted funds as rated by IPD; won the CoreData SMSF Service Provider Awards; and raised $365m in new office, industrial and retail funds.

Direct Office Fund provided 14.8% return over the past 12 months; has been the best performing unlisted fund (Wholesale Unit Class – PCA/IPD) and has a market leading 9.5 year average lease expiry. The innovative Direct Automotive Trust launched in August to overwhelming support.

ABOUT CHARTER HALL

Charter Hall Group is one of Australia’s leading fully integrated property groups with over 23 years’ experience managing high quality property on behalf of institutional, wholesale and retail clients. Charter Hall was API Fund Manager of the Year in 2014.

Métier Medical Ltd Annual Update 2015; Company President Elected to WHO Committee & First Product Orders Shipped

In 2015 Métier Medical widened its footprint as an advocate for safe injection policy and the use of safety engineered injection devices with the election of the Company’s US based President to the World Health Organisation’s committee to assist in the implementation of it’s global Safe Injection policy announced in February 2015.

Supporting the Company’s initiative, development of the Métier Medical Safe-T-Clip™ safety needle with patent pending Secure-Lok ™ locking mechanism was completed in 2015 and is designed to prevent the incidence of needlestick injury to healthcare workers. First orders have been shipped to South Africa and pending orders show a very solid market for the US on completion of FDA around February 2016. Further product development and capital raising will continue into 2016 as the Company aligns itself with the new initiatives of WHO and other international agencies requiring injection devices which feature both Reuse Prevention and Sharps Injury Prevention features.

ABOUT METIER MEDICAL

Needlestick injury and reuse is an endemic problem throughout the developed and developing world with up to 800,000 needlestick injuries estimated in USA alone every year.

Governments globally are moving to legislate the mandatory use of safety syringes and Métier Medical Limited’s Safe-T-Point™ range of retractable syringes including the Safe-T-Point™ Insulin Syringe are a cost effective, safety option for the market.

APN Property Group Annual Update 2015; Completes a Number of Transactions & Launches New Fund

We have completed a number of exciting transactions this year including the sale of 541 St Kilda Road and the redevelopment of The Marketplace, Auburn delivered solid returns for our investors.

We successfully launched the APN Coburg North Retail Fund which is in a good position to deliver sustainable income yield and potential for capital growth over time and the APN Steller Development Fund, a risk-focused inner Melbourne apartment development joint venture which offers an exceptional risk /return profile.

The recently launched APN Convenience Retail Property Fund offers investors a diversified, high quality portfolio focusing on the convenience retail sector. With an initial weighted average lease expiry of 15 years this Fund is very well positioned as a ‘property for income’ based investment.

ABOUT APN PROPERTY

APN Property Group is one of Australia’s leading real estate investment managers, managing $2.1 billion of real estate and real estate securities in 12 funds. Since 1996 we have delivered real estate investment solutions for more than 100,000 investors based on our ‘property for income’ philosophy. A deep understanding of commercial real estate together with a highly disciplined investment approach has been the backbone of our performance.

APN has a market capitalisation of $120M and delivered a total return to shareholders in excess of 40% over the 12 months. APN reported a $12.6m net profit increase in FY15, an increase of 69%.

Avenir Capital Annual Update 2015; Selected as ASX-Listed Future Generation Global Investment Company

Avenir Capital continued to generate attractive long-term returns for our investors via our strategy of investing in fundamental, value oriented and special situation investments in global equity markets.

 In September 2015, Avenir was selected by the ASX-listed Future Generation Global Investment Company as one of their panel of international fund managers. Our selection is testament to our private equity background, the quality of our research and the differentiated investment exposure we provide investors.
Avenir continues to develop its institutional quality infrastructure with the addition of Australian Equity Trustees as custodian of the Fund’s assets.

ABOUT AVENIR CAPITAL
Avenir is a specialist global equities funds manager. Through fundamental, value-based research and analysis our aim is to acquire long-term assets that due to special circumstances and/or internal/external “change” can be acquired at a significant discount to their current or future intrinsic value. Avenir conducts deep company specific research & analysis to identify extreme mispricing opportunities and has disciplined screening to avoid businesses that involve an unacceptably high risk of permanent capital loss.

MBD Energy Ltd Annual Update 2015; Raises $15m

Highlights include:

Successful private equity capital raising:  MBD sought AUD 15M to fund commercial expansion in Australia for the companies high value pigment project and expansion of the companies bioremediation projects in North Queensland.  These funds have been raised over the last 6 months with the final 7M confirmed under a term sheet where the DD has concluded and we are putting in place the 2 agreements to satisfy the term sheet.

On the project front:

Through the capital raising period we continued to experience strong and increasing demand for MBD’s products and services.

  • With MBD’s Astaxanthin project (Red pigment) the company is building a 25 tonne plant. Feedback from the 3 major offtake companies is that individually they are seeking offtake agreements for more than 4 times the plant capacity.
  • With the bioremediation projects MBD have seen demand increase from one farm to 75% of the local industry and the largest operators in Vietnam and Thailand.
  • MBD has a strong and growing pipeline of projects for delivery of high value products and services locally and in Asia.

In June MBD’s Science team’s won the UN (Aust) Water Award on World Environment Day.  The award recognises the world leading achievements of the science team in developing water bioremediation for global applications.

For further information please visit www.mbdenergy.com  There are a number of video’s that will also help your understanding of MBD’s projects and activities.

Below is a link for the astaxanthin project.

http://www.mbdenergy.com/images/video/astaxanthin_2015.mp4

ABOUT MBD ENERGY

MBD is a multi-faceted environmental company that remediates waterways across a wide range of industries and applications and produces a range of high value products for global application. The company provides a cost effective solution to the clean-up of industrially contaminated waste-water while it produces a valuable algal biomass by-products that will generate significant secondary income streams.

The company is also a world-leading producer of Astaxanthin, a highly valued red dye used in the nutraceuticals and food industries.

Analytica (ASX: ALT) Annual Update 2015; Receives 510(k) Clearance with FDA & Raises $2.9m

In 2015, Analytica (ASX:ALT) achieved a critical regulatory milestone receiving 510(k) clearance with the US FDA for the PeriCoach, which along with Australian and European approval, allows the company to sell the product globally. Analytica also undertook a rights issue which raised $2.9 million. The company increased its US sales and marketing efforts with a distribution agreement with Currently Technology Inc and a partnership with SalesForce4Hire. Analytica has an exciting year ahead as it drives towards a licensing deal, identifies new market and commercialization opportunities for PeriCoach and accelerates research and development efforts to make further enhancements to the product.

ABOUT ANALYTICA

Analytica Ltd (ASX: ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.

PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength. The device is low-risk with low manufacturing cost and readily scalable production. Analytica already has regulatory approval in US, Europe and Australia with sales underway.

MediKane Annual Update 2015; Featured on 7 News & Secures 630k in Funding

MediKane’s flagship product was featured on 7 National News in September which increased sales dramatically and assisted acquiring funding of $630,000.

This increased demand required the appointment of a sales manager and two additional directors including a CFO and Marketing. Multiple sales contracts were finalised with pharmaceutical companies, Diabetes Australia, three Australian distributors plus China and New Zealand distributors.

A new hospital product was finalised for distribution through health practitioners and MediKane continues to present at Diabetes Educator webinars, international diabetes conferences, and advertise in diabetes key magazines which deliver sales.

MediKane is growing strongly.

Investors contact info@medikane.com.au.

ABOUT MEDIKANE

MediKane sells high margin products into the gut health and diabetes markets.

The company is at early stage commercialisation and has products selling in Australia and China. The products have been independently demonstrated as being effective by the Royal Melbourne Hospital, medical clinics and diabetes organisations. The products have multiple paths to market, initially via health care practices including medical clinics and naturopaths, and shortly hospitals, dieticians and various diabetes organisations.

Universal Biosensors (ASX: UBI) Annual Update 2015; Share Price up 159% & Revenues up 160%

Universal Biosensors has seen its share price more than double over the year, up from 17.6c on January 5 to 44.5c on December 14 – an increase of 159%.

The company’s financial performance has also been strong, with total revenues in the first half up 160% on the prior corresponding period and quarterly service fees from industry partner LifeScan up 153%. Third quarter results showed continuing strong revenue growth, up 187% on pcp and nett increase in cash of $1M.

Development of new point-of-care coagulation testing systems continue to progress and a new board member, Judith Smith, was appointed.

ABOUT UNIVERSAL BIOSENSORS

Universal Biosensors is a specialist medical diagnostics company developing and manufacturing test systems for point-of-care (POC) medical professionals and home use. UBI’s core technology is a disposable, multi-layer test strip, which uses its proprietary electrochemical sensor to rapidly and accurately measure biomarkers in the blood. The company already has developed products in collaboration with LifeScan (Johnson & Johnson) and Siemens Healthcare.

Kube Systems Annual Update 2015; Receives $2.4m in Orders, $450k in Profit & Features in New York Times

Kube Systems featured in last week’s New York Times in a story on Kube’s “brand standard” relationship with Marriott Hotels.

Kube solves the problem of mobile phone “dead battery anxiety” for customers of hospitality venues – and provides real returns for those venues. Kube is developing data analytics for venues and interactive possibilities for venue customers. The company aims to provide usage stats, demographics, tracking of customer visits and monitoring of charging spots all in real time.

Highlights for 2015:

  • $2.4m in orders and $450k in profit in first year
  • Six distributors world-wide
  • Apple MFi certified
  • NDA with Intel
  • Key customers: Marriott, Starwood, Four Seasons
  • PCT patent application filed.

ABOUT KUBE SYSTEMS

Kube Systems manufactures mobile device charging solutions for the world-wide hospitality industry. Currently in a successful global rollout program, Kube plans then to integrate them into the Internet of Things, expanding into targeted local ad serving and data analytics.

Since commencing in August 2014, the Company has generated A$2.3m in sales, appointed distributors in the US, UK, Europe, ME, Asia Pacific and India, signed key customers such as Marriott and Starwood, and signed a non-disclosure agreement with Intel. The Company is first-to-market with a multi-device wireless charging station capable of satisfying (a) consumers who need power, and (b) hospitality venues looking to retain and engage their customers for longer.

Charter Hall Increases FUM by $900 million from Revaluations

15th December 2015, ASX Announcement

Charter Hall Group (ASX: CHC) (Charter Hall or the Group) today announced that it expects material total valuation gains of approximately $870 million across its funds under management platform. The result is subject to audit review and excludes any other impacts from from normal movements in the balance sheets of the Funds. Further, it is noted that valuation gains will be over and above the Operating Earnings of each the funds.

Charter Hall Group’s co-investments stakes will benefit from an approximate $90 million uplift or 8% growth on the $944 million in Property Investments held at 30 June 2015.

The revaluations are not expected to impact the upgraded Operating Earnings guidance provided at recent AGM of 7-9% growth in Operating Earnings per Security (OEPS) over the FY15 OEPS.

To read the full announcement, please click here

Folkestone Partners ID_Land to Develop New Residential Master Planned Community

16th December 2015

Folkestone is pleased to announce that it has established the Folkestone Wollert Development Fund which has entered into a 50-50 joint venture with ID_Land to develop a 48 hectare residential master planned community in Wollert (“Project”), in Melbourne’s rapidly growing Northern Growth Corridor.

The Project is located within the Wollert Precinct Structure Plan (“PSP”) which is slated for Government gazettal in 2016. The Project will encompass more than 500 residential lots, with an on completion value of approximately $120 million.

Wollert is located in the City of Whittlesea, approximately 25 kilometres north of the Melbourne CBD. Wollert is ideally positioned between Craigieburn and Mernda, and will essentially form a bridge between these two thriving suburbs.

The Project is on the northern side of Craigieburn Road, approximately 3 kilometres east of the Hume Freeway, the main north-south arterial route into Melbourne and 4.5 kilometres west of the proposed Outer Metropolitan Ring Road, which is planned to improve road connectivity between key employment nodes of Melbourne’s north and west.  The Project is also well located between the key employment hub of Craigieburn, Epping Plaza Regional Shopping Centre and the soon-to-open new Melbourne Fresh Produce Market. The Project is located approximately 4 kilometres east of Craigieburn, offering future residents convenient access to the existing Craigieburn Train Station.

Folkestone’s Head of Real Estate, Mr Ben Dodwell said, “Strategically, this project makes sense for us as we are now represented in Melbourne’s key growth corridors – Northern, Western and South-Western.”

“Folkestone and ID_Land are focused on delivering thriving communities and new homes that represent outstanding value” said Mr Dodwell.

Mr Matthew Belford, ID_Land Director said “We are pleased to announce our new joint venture with Folkestone after our very successful partnerships across three of our existing projects.”

To read more, please click here

Altech Chemicals Release Corporate Video

16th December 2015, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce the release of a Corporate Video that provides a useful overview of the various applications of High Purity Alumina (HPA) and the Company’s proposed HPA project at Johor, Malaysia.

To read the full announcement, please click here

To watch the video, please click here

Independent Data and Transaction Services (iDATS) Annual Update 2015; Integrates Technology with Visa

Having integrated our rewards technology with Visa for a rollout in Australia and 17 Asian countries as nominated by Visa under a 5 year data services agreement since being at S&C we are at MOU stage with our first Asian country – Indonesia.

ABOUT iDATS

Independent Data and Transaction Services (iDATS) is a payment industry technology company specialising in the development and automation of programs using front-of-wallet credit, debit and pre-paid cards. The company’s disruptive technology provides Point-Of-Sale (POS) access regardless of financial institution POS ownership. iDATS is an acquirer of merchant and customer data allowing analysis for strategic use.

The company’s technology can engage ~25 million Australian and ~700 million Visa card holders in Asia including, for the first time, debit card users (Australia ~53%). This provides the ability to incentivise customer acquisition and retention enhanced by access to transactional data enabling targeted marketing. iDATS creates a disruption by removing the main barriers of entry, increasing market size and analysing data to generate targeted offers.

Universal Biosensors Investor Newsletter December 2015

As we approach Christmas and the holiday season, we look back at what’s been an eventful year for Universal Biosensors. The year is also ending on a high for innovative companies like UBI with the release of the Federal Government’s innovation policy.

FROM THE CEO’S DESK

Universal Biosensors has had a year of significant progress and development that’s put us in a strong position to grow further in 2016.
Read more.

 FEDERAL GOVERNMENT INNOVATION POLICY

The federal government’s focus on innovation is a welcome development that recognises the importance of our high tech sector and the role it will play in Australia’s economic and social future.
Read more.

Q&A WITH GARRY CHAMBERS, VP OF TECHNOLOGY DEVELOPMENT

“…we are taking a powerful, proven, low-cost system and broadening its application to higher value tests over time.”
Read more.

POINT OF CARE MARKET EXPECTED TO GROW STRONGLY

The point-of-care diagnostics market is forecast to grow strongly in the next five years, with research predicting  the global sector to reach $US18 billion by 2020.
Read more.

SPREADING THE UBI WORD

UBI CEO Paul Wright has been promoting the company around Australia and the world, presenting in almost every Australian capital city and in the US, Asia and Europe.

J&J SYNCS BLOOD GLUCOSE DATA WITH APPLE HEALTH APP

Johnson & Johnson’s LifeScan has announced data collected on its blood glucose devices can now be synced with Apple’s Health app on iPhones.

mm2 Asia Ltd Annual Update 2015; Shares Up 295%; Acquired Majority Stake in Vividthree Productions and Two Cinemas

FY2015 was an eventful year for mm2 Asia. In 1Q2015, mm2 acquired a majority stake in Vividthree Productions, an award-winning 3D animation and VFX company. The Company also raised over S$6m in capital through convertible bonds to expand its businesses.

In a strategic move to expand the Company’s business in the film value chain, mm2 completed the acquisition of 2 cinemas in Malaysia from Cathay Cineplexes Sdn Bhd and signed a binding term sheet to acquire 3 cinemas in North Malaysia. With the incorporation of a new indirect wholly-owned subsidiary, CFO Mr Tay Joo Heng  was redesignated to CEO of mm2 Screen Management Sdn Bhd to manage the Group’s cinema businesses and Group Financial Controller Mr Chong How Kiat was promoted to Group CFO.

In December 2015, the Group announced a share split of 1:2 as well as a placement to raise S$5 million in capital. Continuing its expansion into North Asia, mm2 also signed an MOU to develop television, film and digital content with Hesheng Media, a leading media company in China.

ABOUT MM2 ASIA

Headquartered in Singapore, mm2 Asia is a producer of movies and TV/online content. As a producer, mm2 Asia provides services that cover the entire filmmaking process including securing financing, producing and distributing as well as securing advertising and sponsorship. In addition to Singapore, mm2 Asia also has a presence in Malaysia, Hong Kong, Taiwan and the PRC through its group of companies and/or strategic working partnerships.

mm2 Asia has co-produced and/or distributed in excess of 20 movies across Asia since 2008 including co-producing well-known films such as the ‘Ah Boys to Men’ series; and distributing titles such as Malaysia’s ‘The Journey’ and Taiwan’s ‘Café.Waiting.Love’.

Opal Biosciences Annual Update 2015; Granted New Patents & Raising $3.5m

Opal Biosciences, an innovative player in infectious disease treatment, achieved key milestones in 2015 with its lead “super bug” fighting technology BDM-I. Work started on development of an injectable formulation by a specialist group in the UK. This will enable animal testing to demonstrate the effectiveness of BDM-I in treating infections. Also new screening studies by US labs to examine BDM-I activity against newly emerging antibiotic-resistant bacteria were commissioned. The European and US patent offices also granted two new patents for BDM-I use in treating gut infections and other serious infections such as blood and lung infections. Opal is currently undertaking a capital raising of up to A$3.5 million to continue development of an injectable and topical product, and is considering an IPO in 2016.

ABOUT OPAL BIOSCIENCES

With the rise of life-threatening “superbugs” and few new treatments available, infections are becoming harder to treat driving the need for new anti-infective agents. Opal Biosciences is an innovative Australian biotech company committed to tackling this serious global health threat. Opal’s technologies target human infection: a high growth, commercially attractive market segment.

Opal has a strong IP with extended market exclusivity (granted patents world-wide) and is de-risked with large product range potential. Opal seeks $3.5m investment to develop and commercialise its products, Opal-I and Opal-T. The company’s commercial strategy is to licence or sell to a larger pharmaceutical company within 3 years.

TopBetta Annual Update 2015; Commences Trading on ASX After Raising $6M

TopBetta is the first operator in the Australian market to combine standard wagering platforms with a fantasy platform, including the capability of “fantasy wagering” tournaments, and a mobile content platform.

  • Former Seven West Media chief operating officer Nick Chan is appointed chairman.
  • Fox Sports presenter Matty Johns appointed TopBetta Brand Ambassador.
  • 2016: International Tournaments launched as TopBetta goes global.
  • Exclusive 2016 European Football Championships Tournament in play and Brisbane, Sydney and Melbourne Racing Carnival Tournaments begin, complete with huge cash pools.

ABOUT TOPBETTA

TopBetta is a licensed Australian bookmaker that has developed the first technology platform to combine an online racing and sports wagering offering with a fantasy sports offering that enables sports fans to compete against each other via “tournaments“. TopBetta received eGaming Review Australia’s “Social Gaming Operator of the Year” award in 2014 and 2015.

Newground Property Group Annual Update 2015; Raises $4M in Capital Investment & Secures Over $85m in Sales

Taking advantage of the bouyant property market in 2015, Newground raised $4 million in capital from investors in Brisbane, Sydney, & Singapore.

Noteworthy Highlights:

  • Deal flow continues to be strong with several new project opportunities currently under DD worth $80m
  • Key appointment of Jon Quayle former GM of Investment Sales at Metro Property Development who personally oversaw 1,200 sales last year
  • 80% construction completion of ‘Lush Apartments’ project in Lutwyche Brisbane
  • Establishment of Newground Capital Partners and application submitted to ASIC for AFSL
  • Appeared for the 2nd time in BRW’s Fast Starters list

2016 will see the launch of a number of new projects in locations such as Brisbane CBD, Gold Coast and Woolloongabba. The estimated combined value of these projects is in excess of $120 million.

ABOUT NEWGROUND PROPERTY GROUP

Newground Property is a boutique residential development advisory firm whose capabilities include securing pre-sales, site origination and capital solutions. Founded in 2009, the team have over 45 years combined industry experience and amassed an impressive track record of achieving profitable outcomes for their developer and investor clients.

Due to the growing Brisbane market, Newground’s advisory capability has evolved to include the raising, placement and management of private capital into boutique residential projects located in premium inner city locations. In 2013 NewgroundProperty was awarded a place in the Business Review Weekly’s Fast 100.

Bioactive Laboratories – On Target For a US Launch Within 24 Months

Enormous growth has occurred in 2015. Bioactive has brought forward its drug development pipeline by two years after significant infectious disease discoveries were confirmed by the Walter and Eliza Hall Institute of Medical Research. Collaboration and the formation of a new pharmaceutical company have resulted.

On the back of these discoveries Managing Director Rick Ferdinands was invited by Trade Minister Andrew Robb to attend a tropical medicine event where the company is now discussing funding and commercial opportunities with global philanthropic and pharmaceutical companies.

Furthermore, Bioactive’s flagship ‘stomach friendly’ anti-inflammatory is on target for a US launch of its arthritis supplement within 24 months.
With an investor offer open click here to view the latest Wholesale Investor presentation.

ABOUT BIOACTIVE LABORATORIES

Bioactive Laboratories specialises in plant based enhanced extracts. They have developed an anti-microbial that is potent to one of the worlds most deadly & widespread pathogens affecting over 200m people globally in 2012. The magnitude of this discovery has not been seen since the early 1970’s in a plant based treatment for a major infectious disease.

Consequently, Bioactive have forged a collaboration agreement and formed a new pharmaceutical company with the Walter and Eliza Hall institute of Medical Research (WEHI). Financial returns are estimated within 24 months. In addition, Bioactive is steaming ahead with its anti-inflammatory and pain relieving agent that is gentle to the stomach. A US market entry is planned within the next 12 to 18 months, focussing on the US$1.6billion arthritis supplement market.

Leaf Resources Annual Update 2015; Signs Three MOUs & Raises over $2m

Leaf Resources’ Glycell process reduces the cost of producing clean, cellulosic sugars from biomass, the main feedstock for renewable chemicals and bio-plastics.

Our 2015 highlight updates:

  • GlycellTM sugars cost less than $50 per tonne compared to other sources over $200 tonne, due to the ability to recover the main reagent, glycerol, at a higher purity and therefore higher value.
  • 3 Memorandums of Understanding for particular biomass and feasibility studies on potential plants.
  • Independent scoping study released showed IRR of 81% after tax from a renewable chemical project
  • Edison Report – “GlycellTM has the potential to change the face of global renewable production”
  • Successfully raised over $2M to further advance the commercialization of the GlycellTM process
  • The company was recognized by a selection of international peers to rank in the Top 40 smallest companies in the bio-economy

ABOUT LEAF RESOURCES

Leaf Resources is commercialising the GlycellTM process.

The GlycellTM Process is an innovative technology that uses a low cost, recyclable, biodegradable reagent glycerol, in a simple process that breaks down plant biomass into lignin, cellulose and hemicellulose at low temperature and pressure. The cellulose is then converted to cellulosic sugars through enzymatic hydrolysis and the lignin, hemicellulose and glycerol become valuable co-products.

Cellulosic sugars are a major feedstock for green, renewable biobased chemicals, bioplastics and biofuels, products whose markets are multi $billions and fast growing. Many biobased products can now economically replace petroleum based products.

The GlycellTM process can produce cellulosic sugars at under $50 per tonne when co-products are included. This compares with $220 per tonne for sugars produced from the conversion of corn starch, the cheapest alternative and $280 per tonne for raw sugar.

By dramatically reducing the cost of the main feedstock for bio based chemicals, plastics and biofuels, the GlycellTM process has the potential to change the face of global renewable production.

Bulletproof Annual Update 2015; Revenues up 59% & Raises 3.5m

Bulletproof has had another year of exceptional growth as it executes on its strategy. The company continues to extend its lead as the go-to end to end Cloud Services company on the ASX, and the following highlights characterise the year:
  • Closed FY15 revenues up 59%, and underlying EBITDA up 42% on FY14; revenue growth was supported by 300% YoY growth on Managed Public Cloud revenues and 156% growth in Professional Services revenues as the end to end offering takes hold.
  • Completed the acquisition of Infoplex Pty Ltd on 8 October 2015, for $3.55m. Infoplex is a managed Private Cloud enterprise-focused business with c.$6m annualised revenues. The transaction was supported by a successful institutional capital raising of $3.8m that completed on 23 September 2015.
  • A subsequent Share Purchase Plan to existing shareholders completed on 31 October 2015, raising a further $3.5m (when scaled back), $2m over the expected take up, reflecting strong support for the Company.
  • FY16 Q1 resulted in positive cash flows at the operating line, as the business continues to scale and invest in growth.
  • On 3 December 2015, Bulletproof was awarded Frost & Sullivan’s Managed Cloud Service provider of 2015 award – see http://www.bulletproof.net.au/bulletproof-named-2015-frost-sullivan-australia-managed-cloud-service-provider-of-the-year/ for details
Looking into 2016, the company expects to continue growing strongly, with ongoing innovation and client wins ensuring the Company stays at the forefront of Cloud Services in Australia.

ABOUT BULLETPROOF
Founded in 2000, Bulletproof Group is the leading cloud services provider to business, enterprise and government customers. Bulletproof has consistently been first to market with public and private cloud based services and innovations, including to launch a public cloud service in Australia and the first to launch a managed Amazon Web Services (AWS) offering.

Bulletproof became an AWS Premier Consulting partner in 2013 and was re-certified in 2014.

Martin Aircraft Company Annual Update 2015; Listes On the ASX & Announces Four Major Agreements

Martin Aircraft Company began trading on the Australian Securities Exchange (ASX) under the ticker symbol MJP on Tuesday 24 February. The Company’s oversubscribed listing followed a cornerstone investment agreement with Hong Kong listed KuangChi Science Limited (KuangChi Science) to raise the maximum subscription amount of A$27 million , at an offer price per share of A$0.40 for a total market cap of approx. A$98 million April.  With funding in place company commenced an expansion recruitment program and at year end the company had 53 staff.

The Company launched its first responder jetpack at the 51st International Paris Air Show in June and announced four major strategic co-operation agreements:

  • An agreement with Beijing Flying Man Science & Technology Ltd involves the parties working towards the future delivery of a Martin Aircraft package with an initial tranche of 100 manned Jetpacks, 50 unmanned Jetpacks, 25 static models and 25 simulators.
  • An agreement with Beijing Voyage Investment Ltd a subsidiary company of well-known Chinese-based AVIC International Holdings Ltd for the intended future delivery of manned and unmanned Jetpacks, simulators, and static models.
  • An alliance agreement with Czech Republic-based Martin Aircraft Company s.r.o. to establish a European sales centre for the Martin Jetpack.
  • An alliance agreement with New Delhi based M2K Group Ltd to establish a regional sales presents in commercially important India market.

In September the Company attended both the Czech International Air Fest (CIAF) and  Munich AirTech2015.

The newest prototype P12.3, was registered as ZK-JMK, passed its Sports Aircraft Corporation (SAC) annual airworthiness inspection, and received a New Zealand Civil Aviation Authority (CAA) Manned Flight Permit. This third aircraft in the P12 series differs from previous as it has been built in more of a production-environment, using rigorous build-configuration-controls and processes.

At the Dubai Airshow in November MACL announced that it has signed a Memorandum of Understanding (MoU) with the Directorate of Civil Defence for the intended future delivery of manned and unmanned Jetpacks, Simulators, Spares Parts, Support Services and both Pilot and Engineer training for appropriate Civil Defence and Fire Service personnel.

On 6 December 2015 at Shenzhen China in front of a crowd of 2,400 VIPs and distinguished guests, Martin Aircraft Company in collaboration with KuangChi Science flew the following Manned and Unmanned demonstration of the P12 Martin Jetpack.

A signing ceremony was conducted at the completion of the demonstration to announce the launch of the “Iron Man” Clubs for China with 3 Intention Framework Agreements for a total of 100 manned Jetpacks and 20 simulators.

ABOUT MARTIN JETPACK

Martin Aircraft Company has developed the world’s first practical and commercial Jetpack. Powered by a V4 200hp engine driving two ducted fans, it has been flown to over 3,000 feet and can travel at up to 74km/h.

This aircraft will be the basis for the first commercial release of a Jetpack in 2014, suitable for a Government and Agency market under the banner of “first responder” to service areas such as the fire service, search & rescue, disaster recovery and border security.

Unity Pacific – Sentinel Makes Conditional Offer to Fund Buyback

15th December 2015, ASX Announcement

Unity Pacific Limited (ASX: UPG) makes the following announcement in response to an offer made by Sentinel Property Group (Sentinel), a privately-owned and Brisbane-based property group.

Sentinel has today announced an offer to fund a buyback of all the stapled securities in Unity Pacific Group (the Sentinel Offer).

The Sentinel Offer is subject to the completion of previously announced of Unity Pacific Group’s investment property located at 308 Queen Street / 88 Creek Street, Brisbane and the return of the net sale proceeds to securityholders.  Securityholders approved the sale of the property at the annual general meeting held on 19 November 2015. The sale process is expected to commence in early 2016 and if successful, is anticipated to be completed in mid-2016.

To read the full announcement, please click here.

Serrano Limited Annual Update 2015; Launches New Interior Design & Home Renovation Business

Leveraging the Group’s success as a leading provider of interior fit-out solutions in Singapore and Southeast Asia, Serrano Limited is set to redefine the interior design and home renovation spaces by advocating high standards of quality and reliability.

Offering customers a comprehensive holistic experience, its new concept showroom with the “Serrano Experience Centre” will educate homeowners on “Home Renovation 101”, and its semi-automated state-of-the-art production facility will ensure consistent, high quality furnishings.

Supporting this business segment is its team of experienced professionals who will guide homeowners through their home renovation journey focusing on their needs and ensuring they make informed decisions throughout the whole process.

ABOUT SERRANO

Serrano Limited is a leading provider of interior fit-out solutions for property development and refurbishment projects in Singapore and Southeast Asia. Its portfolio spans the residential, hospitality, retail and commercial sectors, with a focus on mid to high-end private residential developments.

Some of its significant projects include prestigious developments such as The Interlace, Reflections at Keppel Bay, Ritz-Carlton Residences, ICON @ Tanjong Pagar and the Youth Olympic Village (Nanyang Technological University) in Singapore; the Star City Thanlyin township development and Traders Hotel (now known as the Sule Shangri-La Hotel) in Myanmar; The Estella in Vietnam; and The Met and The River in Thailand.

As a testament of its leading position and commitment to quality, the Group has won numerous awards and certifications. These include The Business Times and KPMG – Enterprise 50 Award in 2014, the Singapore Prestige Brand Award – Established Brand in 2013 and 2014, the Asia Pacific Brands Award Singapore’s Finest in 2014, the Singapore Furniture Industry Awards – The Furniture Manufacturer Award (Gold) in 2013, the Built Environment Industry Asia Awards – Regional Award of the Year for Outstanding Business Achievement in 2013, the ASEAN Business Awards – Most Admired ASEAN Enterprise – Growth (Large Company) in 2013, and the ISO 9001:2008 Quality Management System Certificate for wholesale and distribution of furniture and project management for residential/building furnishings from December 2013 to December 2016.

Parrot Analytics Annual Update 2015; Launched Industry’s First Ever Demand Metric & Published in Key Industry Publications

Parrot Analytics has had an amazing year in 2015, with a growing & diverse team of talented individuals from the intersections of media, technology & entrepreneurship – we have made great strides toward building on our vision to help TV executives make better content-related decisions across the industry’s value chain. With a developed product suite of Demand Portal to Intelligence Reports, Parrot Analytics now works with large, global broadcasters in over 100 markets to regional over-the-top (OTT) platforms.  

The launch of the industry’s first ever demand metric: Demand Rating™ – a cross platform, country-specific, real time demand measure – created ripples in the industry as reported in key industry publications, such as VarietyScreen InternationalInquisitrIndependentBusiness Insider,  WIRED and others. We have also presented as thought leaders at Variety SummitsMIPTV,  Edinburgh TV FestivalINTX and soon to be presenting at CES 2016

ABOUT PARROT ANALYTICS

Parrot Analytics has developed the industry’s first and only country-specific demand rating platform for TV, film and cross-platform content for existing and new releases. Parrot’s patented next-generation technology helps TV and film producers, content buyers, sellers and advertisers make more effective content decisions.

It does this by capturing and analyzing TV content demand in real time from hundreds of millions of viewers across the world and in individual local markets; providing unprecedented insights into global content demand and predicting future country-specific content performance across demos with a high degree of accuracy.

Troozi Annual Update 2015; Reports 55% Increase in Memberships to Over 400m Users

Troozi completed a seed round of funding in 2015 and continues to attract interest from India’s expanding singles population in major cities, recording a 55% increase in membership growth in 2015. India’s trajectory in social media and mobile penetration continues to surpass all forecasts with India poised to become the 2nd largest internet market in the world by the close of 2015, surpassing the US with over 400m users recorded in December. Troozi has focused on mobile development in recent months, releasing a new Android App next week ahead of the new year boom in dating. The company is opening expressions of interest in January 2016 for next round investment to support a national marketing campaign in India.

ABOUT TROOZI

Troozi is an online dating platform for modern Indian singles. Troozi is device agnostic with an integrated experience across web and mobile and native apps in progress. Already, over 100,000 members have signed up through the proof of concept phase.

Founded by former executives of RSVP, Australia’s leading dating site, the team have their sights firmly on becoming India’s largest and most preferred meeting place for singles.

SUDA Ltd Annual Update 2015; Advances Pipeline & Begins Deal Negotiations

SUDA LTD has advanced its pipeline of OroMist® oral sprays in 2015 including finalising the design of pivotal trials for two of its lead products and a successful meeting with FDA. The Company has made significant progress towards its business development goals to out-license its products to the pharmaceutical companies across the world.

Discussions with prospective partners span SUDA’s novel sublingual antimalarial spray, ArTiMist™, and its oral sprays for insomnia, migraine, nausea, and erectile dysfunction, as well as the application of SUDA’s OroMist® technology to new compounds. Discussions are at various stages with some companies having completed due diligence and initiated deal negotiations.

The Company’s operations have expanded in 2015 with the addition of new staff as well as the formation of SUDA Europe in London, UK, to widen its business development footprint and provide access to further grant funding and the UK patent box.

SUDA anticipates that 2016 will be an exciting year for the Company with the prospect of securing several commercial deals, creating significant shareholder value.

ABOUT SUDA

SUDA Ltd (ASX: SUD) is a drug delivery company focused on oro-mucosal administration, headquartered in Perth, WA. The Company is developing low-risk oral sprays using novel formulations of existing pharmaceuticals. The many potential benefits of administering drugs through the oral mucosa (ie: cheeks, tongue, gums) include ease of use, lower dosage, reduced side effects and faster response time.

SUDA’s product pipeline includes first-in-class oral sprays for insomnia, malaria, migraine, nausea and vomiting, erectile dysfunction and pre-procedural anxiety.

iFAST Corporation Annual Update 2015; Launches Distribution of Bonds & ETFs, Receives Approval For Asset Management in HK & Wins Multiple Awards

In May, we officially launched the distribution of bonds and Exchange Traded Funds (ETFs) as part of our main investment product offerings to investors and wealth advisers in Singapore. In August, we received the approval to carry on Type 9 Regulated Activities (Asset Management) in Hong Kong, where we subsequently launched our Online Discretionary Portfolio Management Services on Fundsupermart.com, our B2C platform. In October, our China subsidiary was awarded a Funds Distributor Qualification from the China Securities Regulatory Commission, allowing us to run an investment funds platform in China. Other than that, we also received the “Most Transparent Company Award 2015, New Issues Category” at the SIAS Investors’ Choice Awards 2015 in Singapore. For more information, please refer to www.ifastcorp.com.

ABOUT iFAST

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Listed on the SGX-ST Mainboard, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia.

The company is also present in Hong Kong, Malaysia and China. iFAST Corp has two main business divisions, the B2C business with its Fundsupermart.com transactional website and a B2B business catering to over 150 banks, FAs and financial institutions using its platform.

Spotlight Reporting Annual Update 2015; Raises NZ$2m & Secures a Number of Enterprise Deals

  • Spotlight has raised NZ$2 million of a $4 million round, which will close early in 2016. Existing high profile investors such as Craig Winkler (MYOB, Xero) invested in the current round.
  • Team has grown from 12 to 23 in 2015 and we added Graham Shaw (Xero) and Miki Szikszai (Vend) to our Board as Directors.
  • We have secured a number of enterprise deals, including with Deloitte and KPMG. We continue to build on existing strategic partnerships with Xero and Intuit.
  • A popular highlight has been the launch of our Forecasting v2 cloud product, now used by many leading accounting firms and businesses.
  • As ever we had a busy schedule, attending Xerocons across the globe and QuickBooks Connect in California, amongst others.
  • Thrilled to win Xero Add-On Partner of the Year and to be recognised in the Deloitte Asia-Pacific Tech 500 fast growth rankings (at #179). We were also a Deloitte Rising Star this year.

Recent Media Releases:

Spotlight Reporting scoops Xero award
Cloud-based accountancy firms Spotlight Reporting and RightWay in partnership
Coaxing accountants into Spotlight
Ex-Xero executive joins Spotlight Reporting
Startup profile: Richard Francis from Spotlight Reporting
Newcastle to showcase New Zealand trade collaboration ahead of All Blacks’ Rugby World Cup visit

ABOUT SPOTLIGHT REPORTING

Spotlight Reporting is a Wellington-based software company providing business intelligence reporting tools to over 9000 accountants, advisors and business owners world-wide. The revolutionary software imports financial and non-financial data to automatically create powerful reports, performance dashboards, cash-flow forecasts and multi-entity reporting.

Spotlight Reporting offers superior customisation and template options designed by accountants, consolidation and multi-currency features and support services and expertise at all stages of the journey. Spotlight Reporting was voted Xero Add-on Partner of the Year 2014.

Acoustic3D Holdings Annual Update 2015; Announces a Technology-Transfer Agreement and Raises $1m

  • Acoustic3D Holdings Ltd, A3HL – announces a technology-transfer agreement with Vastigo Ltd, Singapore.
  • Vastigo licenses A3HL technology for smartphones, televisions, car-audio, ceiling speakers and consumer audio
  • A3HL raised ~$1Million AUD to fund global licensing, as per Deloitte’s advice.
  • A3HL subsidiary, NewAudio Pty Ltd’s new website www.newaudio.com.au, markets Emergence AS8’s directly to consumers and through Professional AV outlets. NewAudio plan to distribute an expanded range, including sound-bars, through large retail-chains.
  • A major European car audio group initiated trials of A3HL technology.
  • Vastigo’s sales campaign starts at the 2016 CES, Las Vegas.
  • Capital raising in Australia is complete. However, a few shares in A3HL are available on the secondary market.

ABOUT A3D

Acoustic3D has developed patented acoustic technologies that use new thinking in physics, mathematics and psychoacoustics, to enhance the human perception of sound, therefore creating greater clarity, spatial awareness, and increased intelligibility.

The Company’s first generation reflector product known as the ‘Emergence’ sound system, won the ‘Australian Good Design Award’ in 2014 and has created much interest from major consumer electronics manufacturers with regard to licensing the technology.

Acoustic3D will change the way people listen to sound with a patented, game-changing discovery in audio amplification; the audio hologram. Holograms produce 3D sound of unprecedented clarity and depth, almost 100% distortion-free, recreating the original room acoustics for the listener.

A series of low cost, audiophile-quality consumer and studio systems are production-ready. Acoustic3D will be ideal in concert halls, airports and railway stations. Funding is required to bring the final products to market and cash flow the business through this launch phase.

Altech Chemicals Annual Update 2015; Achieves EBITDA of US$59.4m & Secures Significant Project Funding

Altech successfully completed its BFS in June 2015 with positive financial results: total capital costs US$77 million; project payback 3.8 years, internal rate of return of 30.3%; annual EBITDA at full production US$59.4 million; and a NPV of US$326 million.

Project funding is full steam ahead with support from German federal bank KfW-IPEX and export credit agency (ECA) Euler Hermes for potential ECA and senior debt funding of ~US$40m – at attractive interest rates and long tenure (subject to due diligence). With major financiers backing the HPA project, and Mitsubishi confirmed as Altech’s Japanese HPA sales/off-take partner, construction of the Company’s HPA plant looks likely to commence by early 2016.

ABOUT ALTECH CHEMICALS

Smart investors understand the windfall gains to be made from taking an early position in companies set to profit from exposure to the “new age materials” boom. Altech Chemicals share price has almost doubled since July following release of its Bankable Feasibility Study (BFS) for construction of a 4,000tpa High Purity Alumina (HPA) plant at Tanjung Langsat, Malaysia. And no wonder – the project has an NPV of US$326.1 million (10% discount) and capital costs of a meager US$76.9 million.

There is no substitute for HPA in LED manufacturing, HPA demand is growing at a staggering 28% pa.

RewardBet Annual Update 2015; Granted Four Patents & Signed a World-Wide License Agreement

RewardBet.com provides what’s been called the most innovative product for wagering and gaming in decades. Shareholders include significant industry representatives and specialists.

In an industry that is very competitive but also extremely profitable, RewardBet was granted/accepted four patents in South Africa, Singapore, New Zealand and Australia this year. There are around 50 countries pending.

Highlights are:

  • Signed world-wide license agreement with leading international virtual sports and racing provider; revenue expected Q1 2016.
  • Advanced talks/NDAs with many operators in Australia and internationally. Multiple revenue flows expected in 2016.
  • An extremely lean operating base (close to cash-flow positive with only a proof of concept site) with a very profitable software licensing/turnover model augurs well for future expansion across virtually all operators world-wide in the racing, sports and casino industries.

ABOUT REWARDBET:

RewardBet is a patent protected (50+ countries; granted and pending) and award winning product designed to significantly enhance the betting experience for customers, and increase revenue for operators across: Racing, Sports and Casino betting.

Invented by an Internet Betting Pioneer,RewardBet has been rightly described as the most innovative development in wagering and gaming for decades. With a world-wide licensing agreement already signed, a track-record of engagement which will lead to further deals and two rounds of investment behind them, RewardBet is seeking funds to realise their global potential.

Atomo Diagnostics Annual Update 2015; Secures Commitments for Over US$8m

  • Atomo Diagnostics secures commitments for over US$8 million to support continued global rollout
  • Atomo has executed a Term Sheet with a leading Global Impact Fund and received preliminary board approval from the fund for an investment totalling US$8million. The investment, a combination of a loan and equity, will be used to scale up of Atomo’s manufacturing capabilities.
  • Additionally, Atomo was awarded a grant of A$1.8 million from the NSW Medical Device Fund to commercialise a HIV self-test solution. To complete its capital activity, Atomo is seeking up to US$4 million in additional equity and intends to finalise the capital raise by February 1, 2016.

ABOUT ATOMO DIAGNOSTICS

Atomo Diagnostics is an emerging and multi-award winning medical devices company that has commercialised AtomoRapid™, the world’s first ever integrated rapid blood test. AtomoRapid™ makes obsolete longstanding “bits in a box” test kits. Improved safety, reliability and convenience with AtomoRapid™ results in overwhelming user preference.

Atomo is proving its commercial success, satisfying export driven demand for HIV, Malaria and Ebola. Atomo’s continued growth across diagnostic markets include a self-test solution targeting growing consumer markets, with Atomo agreeing to work with a global pharmaceutical company to launch and distribute Atomo’s consumer test range in Australia and New Zealand.

OncoSil Medical Appoints Charles Rowland as President

15th December 2015, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce the appointment of Mr. Charles Rowland as President, OncoSil Medical USA.

Mr. Rowland was previously President of Sirtex Medical US from 2002 to 2006, and is a highly experienced healthcare executive with a successful record of commercialising medical devices and growing medical device companies in the diagnostics, cardiac patient management and liver cancer markets.

In his role with OncoSil Medical Mr. Rowland will be responsible for developing and executing the Company’s US Business plan and will be the Company’s official representative with the US FDA as it works towards US licensure  for its lead product candidate, the OncoSilTM localiased radiation treatment for cancer.

To read the full announcement, please click here

“In Virtual Reality Headsets, Investors Glimpse the Future” – 8i Featured in Monday’s NY Times Business Section

13th December 2015, The New York Times By Nick Wingfield

Magic Leap, a secretive company making wearable technology for mixing digital imagery with the real world, is seeking to raise $827 million. Jaunt, maker of a 3-D camera for filming virtual reality video, has nabbed a total of $100 million, including $65 million in September. And 8i, which makes technology that lets people interact with video of humans as though they were in the same room, has raised nearly $15 million.

None of these start-ups is a household name. Few members of the public have had an opportunity to interact with — much less buy — the virtual and augmented reality technology that these companies are developing.

Yet investors and entrepreneurs believe that headsets made to immerse people in digital worlds are the next giant moneymakers in technology, setting off an investor frenzy rarely seen since the early days of the web and mobile markets. Virtual reality start-ups are multiplying, venture capital is pouring into them and the believers are expressing blue-sky thinking about how the new products could reshape entertainment, communications and work.

To read the full story, please click here

BPS Completes Funds Raising and Acquisitions

14th December 2015, ASX Announcement

BPS Technology Limited (“BPS”) (ASX:BPS) is pleased to announce it has finalised the issue and placement of Convertible Notes at $1.175 per share conversion ratio and raising a total of $5 million on terms favourable to the Company.

Key highlights: 

  • Strongly supported institutional placement
  • Three new Listed Investment Companies join the register
  • Funding for earnings accretive acquisitions

The proceeds will be used to fund earnings accretive acquisitions and to further accelerate merchant growth in our key strategic areas.

BPS can announce that these new funds have, in part, been immediately applied to the purchase of two additional key Bartercard Franchise territories. In doing so, this will accelerate the joining of new merchants and assist in the rollout of the bucqi payments and loyalty platform which is currently being launched in selected areas within Queensland.

To read the full announcement, please click here

YPB Capital Raising Update

14th December 2015, ASX Announcement

The Board of YPB Group Limited (ASX:YPB) advises that the Company is in continuing discussions with potential cornerstone investors to support the continuing growth of the business. The purpose of the proposed capital raising is to fund the previously announced pending acquisition of Motif Micro Inc. and provide additional working capital.

To view the full announcement, please click here.   


BioDiem Offer Closing Today

Dear Shareholder,

You should have received by now

  • a copy of our current BioDiem Prospectus; and
  • a personalized entitlement and acceptance form, including BPay details.

Should you not have received these or require replacements, please contact Rachel Kiely at our office on (03) 9692 7240.

The Prospectus is available on our website.

Should you wish any additional information, please contact Rachel on info@biodiem.com

To view the prospectus, please click here

OncoSil US FDA Investigational Device Exemption Submitted

14th December 2015, ASX Announcement

OncoSil Medical Lmited (ASX: OSL) (OncoSil Medical, the Company) is pleased to announce that it has filed an Investigational Device Exemption (IDE) with the US Food and Drug Administration (FDA) for its lead product candidate, the OncoSilTM localised radiation treatment for cancer.

This is a significant milestone in the development pathway for OncoSilTM in pancreatic cancer and is the firsts step towards securing FDA commercial approval for OncoSilTM under a Pre-market Appoval (PMA).

Subject to an IDE being granted, OncoSil Medical will commence a clinical study under the FDA to support the PMA. A PMA will allow the Company to commercially market OncoSilTM in the USA.

The company formally filed its IDE submission on 10th December 2015 after successfully completing a lengthy pre-IDE process. The pre-IDE process involved an FDA review of the proposed Clinical Investigational plan including the endorsement of clinical endpoints and outcomes measure.

To read the full announcement, please click here.   

Further US Patent for Opal Biosciences’ Antimicrobial, BDM-I

14th December 2015, BioDiem

BioDiem Ltd is pleased to announce that a further US patent has been granted and published for BDM-I.

The claims cover treatment of a range of infections including:

• potentially life-threatening infections

  • caused by bacteria such as Methicillin-resistant Staph aureus (Golden Staph) and also Mycobacterium tuberculosis (TB) and Streptococcus pneumoniae and Haemophilus influenza which can cause serious infections, including such as systemic and respiratory infections;
  • caused by fungi such as Candida albicans and glabrata, and Aspergillus fumigatus among others; and

•  common superficial infections caused by the fungi responsible for skin infections like tinea or athlete’s foot.

These claims support the strategy of BioDiem’s Opal Biosciences to develop treatments for serious infections, such as can occur in those patients recovering from cancer treatment where the immune system is weakened, and also a topical treatment (ointment/gel) for treatment of simpler infections of the skin.

To read the full announcement, please click here

Crowd Mobile CommSec Interview Available for Viewing

11th December 2015, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (the Company) is pleased to advise that recording of an interview of the Company’s CEO Domenic Carosa, by Tom Piotrowski of CommSec is available for viewing on the Company’s website.

To watch, please click here

To read the full announcement, please click here

 

SUDA Amends Agreement with Amherst Pharmaceuticals

10th December 2015, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has amended its agreement with Amherst Pharmaceuticals in relation to ZolpiMist for insomnia and SUD-002 for nausea and vomiting.

Under the terms of the new agreement, SUDA has expanded it territorial rights to ZolpiMist to include South America, Central America and South America. As a result, SUDA now has a global license, excluding North America , to this US-registered oral spray of zolpidem tartrate for the treatment of insomnia. As per the cross-licencing agreement signed in January 2015, SUDA will pay Amherst a 6 to 12 per cent share of income from SUDA’s commercialisation of ZolpiMist. Business development discussions with prospective partners are progressing in several countries, including in the expanded territory.

To read the full announcement, please click here

Altech Receives Letter of Interest for German ECA Cover

10th December 2015, ASX Announcement

Highlights:

  • Letter of Interest (LOI) received from Euler Hermes for German export credit cover (ECA)
  • Approximately US$40.0 million of project capital estimated to qualify for ECA cover
  • Debt supported of ECA cover is typically at attractive conditions, including long tenure

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to report that following a recent presentation to  Euler Hermes Aktiengesellschaft (“Hermes”) in Hamburg, Germany and its preliminary evaluation of the Company’s proposed high purity alumina (HPA) project, Hermes has issued a Letter of Interest (LOI) confirming in principle support under the export credit insurance guarantee scheme of the Federal Republic of Germany (ECA cover).

The LOI is based on the information provided and subject to further in-depth due dilligance. In addition, the LOI is not legally binding and has been issued without prejudice to any decision of authorities to provide cover for this project.

To read the full announcement, please click here.  

Booodl Thinks Big to Get $2.85 million from Westfield Owner

9th December 2015, Start Ups Smart By Denham Sadler

Startup founders need to look for investments from large corporates instead of trying to disrupt them, Booodl co-founder George Freney says.

The local shopping app has just closed a $2.85 million strategic investment led by Scentre Group, the owner and operator of Westfield in Australia and New Zealand, opening up a whole new world of customer and retail opportunities for the startup.

More entrepreneurs need to be willing to work with bigger, more established businesses to achieve deals like this, Freney tells StartupSmart.

“This shows how big business and entrepreneurs can work together,” he says.

“If a big business can provide distribution and exposure to help grow your business then it can make good sense as an investor and partner.”

To do this, startups need to gain market traction and then pinpoint the appropriate businesses to partner with, he says.

“Make sure you’ve got a great product and a market that’s responding to it,” Freney says.

“Then identify the corporations that are playing in the marketplace that you are, and speak with them – a lot more people will say yes than you think.”

To read the full article, please click here

Crowd Mobile Chairman’s Address and CEO’s Presentation to Shareholders at 2015 AGM

9th December 2015, ASX Announcement

The Company’s results in what is essentially the business’s first financial year since listing on the ASX were strong; revenue was up 31.8% to $12.98 million for the financial year ended 30 June 2015. The Company achieved strong revenue growth across each of the FY15 quarters, and its key performance metrics of message volume, new territories entered and products in the market all increased.

Reflecting the emphasis on the Company’s objective of growing the existing business, launching new service offerings and progressing the acquisition strategy, the Company reported a loss for the year of ($3.95) million, although notably, this included a $3.11 million non-cash share based payment charge to effect the reverse takeover of Q Limited, transaction fees for the same of $0.25 million, a $1.12 million non-cash share based payment charge for the Company’s performance incentive plans to Executive Director and staff, and transaction fees for the now-completed Track Holdings acquisition, of $0.40 million.

To read the full announcement, please click here

To view the CEO’s Presentation, please click here

 

DomaCom Launches $410m Crowdfunding Campaign for Kidman Station

8th December, 2015, Sydney Morning Herald, By Sally Rose

A $410 million crowdfunding campaign is being pitched to self-managed super fund investors in a bid to keep S Kidman and Co, the country’s largest landholder, majority Australian owned.

Self-described “fractional property investing platform” DomaCom has structured the proposed deal based on a valuation of $400 million to $410 million. That would provide a $30 million to $40 million sweetener to vendors the Kidman family, compared with the reported $360 million to $370 million Chinese bid that was blocked last month when Treasurer Scott Morrison ruled the sale was not in the national interest.

The 101,000-square-kilometre cattle property, which represents 2.5 per cent of the nation’s agricultural land, encompasses the Department of Defence’s prohibited area at Woomera in northern South Australia used for top secret weapons testing.

Professional services firm EY, which is acting on behalf of S Kidman and Co in the sale process, is still in negotiation with Chinese suitors and is expected to come back with a revised deal for the sale of part of the property.

“The Kidman family should not feel rushed into accepting an offer from China when this alternative is on the table that would give them a better price, allow individual family members to retain a stake if they wanted to, and better protect the national interests in terms of both national and food security,” DomaCom chief executive Arthur Naoumidis said.

Stephen Burgin, a senior adviser with the InterPrac dealer group of financial planners, spearheaded the idea of using DomaCom to crowdfund the rival bid to get retail investors in on the biggest land sale deal in the nation’s history. Mr Burgin is also a seventh generation pastoralist whose family runs 22,500 acres in western Victoria.

“There has been a lot of commentary about how Australia needs foreign investment, but we don’t, we’ve got $2 trillion locked up in super,” he said.

Mr Naoumidis expects the offer will illicit a strong response based on both its “emotional” and financial appeal.

To read the full article, please click here.

DomaCom Kidman Station Investment

Wednesday December 9, 2015

Keeping the Kidman Station in Australian hands

Mum and Dad investors could get the opportunity to become part-owners of one of Australia’s agricultural icons, Kidman Station, via a radical proposal to open up the sale to crowd-funding.

Crowd-funding has typically been associated with retail and commercial property, but this proposal, the brainchild of seventh generation pastoralist Stephen Burgin and crowd-funder DomaCom, would put the $360 + million Kidman properties “into play” for retail investors.

Burgin says this is a “wonderful opportunity” to give Australians the opportunity to invest in part of the country’s agricultural heritage. Opinion polls show there is enormous concern among ordinary Australians about retaining our “food-bowl properties”, as well as the businesses that flow from them, and this would be a concrete way to act on that concern.

The Kidman Station is an aggregation of 17 pastoral properties and three supporting properties in breeding, feedlot and cropping. It is spread across Queensland, the Northern Territory and Western Australia and is home to 185,000 cattle. At 101,000 square kilometres, it is larger than Ireland and almost half the size of Victoria.

DomaCom Chief Executive Officer Arthur Naoumidis says its ASIC registered platform provides the “ideal vehicle” to give Mums and Dads the chance to invest in the Kidman estate.

“Crowd-funding hasn’t traditionally been associated with pastoral properties, but that’s no reason why it can’t be done. The platform is structured to cater for the smallest apartments to a deal of the Kidman magnitude.
The principle is the same, and people can get on-board the Kidman acquisition for as little as $2500 and receive a proportional share of the income and capital value of the property that will be valued annually.

It is also a good opportunity for superannuation funds, whether they be APRA-regulated or SMSFs, to get a slice of this pastoral empire that offers an indicative rent yield of about 9% a year.”

Burgin says long-term holdings in key quality agricultural and pastoral assets make good commercial sense as part of anyone’s investment portfolio.

“Direct property in a diversified portfolio can assist in providing stable returns with the potential for significant gains in the longer term. Many younger Australians are disengaged with their super, but this is a rare opportunity to have an active interest in Australia’s future.”

The Federal Treasurer, Scott Morrison, has blocked a proposed sale based on a FIRB assessment that suggests it is not in Australia’s best interest to have foreign ownership of the Kidman Station.

Burgin says there are many opportunities for ordinary Australians to invest in agricultural properties with the Kidman Station not the only significant asset on the radar. “We are actively looking at placing significant funds towards further acquisitions.”

He says the economic rewards and future food security are primary motivators to acquire Kidman Station. Last year it generated a net profit of more than $50 million or around 15% return on capital.

The crowd-funding campaign will separate the land from the operating business with the land expected to yield about 9% rent and the operating business expected to yield about 20% annually.

“There is plenty of upside in a growing export market for agricultural produce that should continue to improve if the dollar makes further retreats. The domestic and international appetite for quality Australian produce continues to grow each year,” Burgin says.

To download the full article and the Investment Brochure, please click n the links below. 

Booodl Closes $2.85m Strategic Investment Round

8th December 2015

Booodl, the smart local shopping app, today announced the completion of a $2.85m strategic investment round that was lead by Scentre Group, the owner and operator of Westfield in Australia and New Zealand.

The Booodl app and website uses geolocation and machine learning to help consumers find physical retail stores that sell products they want.

Users of the app can then save these products to a list and receive reminder notifications whenever they’re near a store that sells one, helping to drive more relevant customers in-store.

Consumers can also message stores via the app to confirm details such as price and availability, and pre-purchase products from retailers that have enabled the ‘Pay & Pickup’ feature. This reflects a significant global trend around consumer-to-business messaging and in-message transactions.

There are currently over 15,000 stores across Australia that can be discovered through Booodl. The $2.85m investment will be used to accelerate store growth and user acquisition.

“Our mission is to help all stores get found by shoppers who want their products,” said Booodl Co-Founder and CEO, George Freney.

“To achieve this we’re in the process of building the most comprehensive and intelligent retail store directory out there, down to the category, brand and product level. It’s no small technical feat,” said Freney.

The physical store is the heart of the shopping experience, yet stores still miss crucial opportunities to engage with nearby shoppers, and users waste countless hours trying to find and buy what they’re after. Connecting the two was a logical step for Booodl and one that resonated with Scentre Group.

To download the full article, please click on the link below. 

BIG Signs Sponsorship Agreement with Australian Finance Provider

8th December 215, ASX Announcement

Highlights:

  • Big UnLimited business activates the first of its additional revenue streams and signs first member sponsorship agreement with First Class Capital, a leading Australian finance provider (“FCC”) to the SME market
  • Agreement expected to generate over $300,000 up to the March 2016 quarter, from initial sponsorship and advertising initiatives, with potential for further monetisation opportunities
  • Select Australian BRTV members to be offered First Class Capital sponsorship
  • Pre-roll branding to be incorporated into Big Review TV video content
  • Strong pipeline of further revenue opportunities expected to be announced in the coming months

Big UnLimited (ASX:BIG, ‘BRTV’ or ‘the Company’) is pleased to announce sponsorship agreement with First Class Capital (FCC) The agreement has been specially tailored to meet the potential needs of Big Review TV’s 13000 + SME membership base.

First Class Capital provides specialist finance for small retail businesses. The sponsorship agreement initially targets Australian SME’s with the potential to expand as Big UnLimited’s membership grows overseas. The company will initially offer FCC sponsorship opportunities to existing Big Review TV members.

To read the full announcement, please click here

YPB to Acquire Smartphone Readable Authentication Technology & Investor Presentation

8th December 2915, ASX Announcement

Highlights:

  • The ‘Holy Grail’: non-replicable identifier technology , readable by smartphone
  • Award-winning, patented technology developed at Massachusetts Institute of Technology
  • Potential to become global authentication standard
  • Multiple end applications
  • Highly complimentary with current YPB offering

YPB Group Limited (ASX:YPB)  has signed a Letter of Intent (LOI) for the acquisition of Motif Micro Inc., a company commercializing secure, smartphone-readable microbarcode technology  originally developed at Massachusetts Institute of Technology (MIT). This represents a key step in the execution of YPB’s PROTECT, DETECT, CONNECT strategy.

Motif Micro’s platform is considered the ‘Holy Grail’ of non-replicable technology due to its ability to uniquely encode products at the item level while maintaining ultralow cost, high physical security, exceptional visual appeal and reliable smartphone readout. With this technology, YPB will commence production of microparticle barcodes from proprietary polymer nanocomposites for authentication of a vast array of goods.

To read the full announcement, please click here.

To view the Investor Presentation, please click here.   

Altech Chemicals- Kerrigan Exploration Licence Granted and Investor Presentation

8th December 2015, ASX Announcement

Highlights:

  • Grant of Exploration License E70/4718 (Kerrigan)
  • Inferred of Kaolin Mineral Resources of 85Mt (JORC 2004)
  • Proximal to established road and rail infrastructure

Altech Chemicals Limited (Altech/ the Company) (ASX: ATC) advises that exploration license E70/4718 (Kerrigan Project) has been granted. The license covers an area of approximately 480km2, is on freehold agricultural land and contains Inferred Kaolin Mineral Resources of 85 million tonnes at 85.1% brightness (JORC 2004)(refer ASX Announcement by the Company dated 24 August 2011 for details).

The Kerrigan project is located approximately 20km south of the Western Australian wheat belt town of Hyden and 335km south east of Perth. The project is proximal to the Hyden to Lake Grace railway line (15km to the east), which connects to the port city of Albany, Western Australia; there are also established sealed roads from Hyden to Perth and the ports of Albany, Bunbury, Esperance and Fremantle.

To read the full announcement, please click here

To view the Investor Presentation, please click here

Tesserent Helps to Ward Off Hack Attacks

8th december 2015, The Australian, By Simon Hermann

In 2013, Scandinavia’s largest independent research organisation, SINTEF, reported that 90 per cent of today’s data has been created in the past two years. Software giant Oracle projects that data available to consumers will grow at a 40 per cent compound annual rate, reaching almost 45 zettabytes by 2020. With more and more businesses shifting to the cloud, consumer protection becomes increasingly important. No wonder then that concerns surrounding the privacy and safety of personal date abound.

While this trend provides opportunities for cloud computing and technology companies, one of the fastest-growing industries is cybercrime. These cyber-criminals have become an everyday part of the industry

Software companies across the world are developing ways to counteract these criminals and protect data. Several technology and software companies offer cyber security as a service.

Tesserent is the first pure play internet security company to list on the ASX. Tesserent aims to capitalise on the increasing volume of cybercrimes.

Tesserent has more than 190 clients in 11 countries and achieved total revenue of $3.7 million during the 2015 financial year. The company seeks to raise up to $7m in the initial public offer scheduled to conclude in February. The proceeds will be used to repay existing debt, fund domestic and international expansion as well as for general working capital.

To read the full article, please click here

BioDiem Presented at the Wholesale Investor Showcase Sydney

7th december 2015, BioDiem

BioDiem’s CEO, Julie Phillips presented at the Wholesale Investor Sydney Capital Expo and Small Cap Showcase, held at Menzies Hotel in Sydney on 4th December 2015. The event was designed to showcase Australia, New Zealand and Singapore’s most innovative companies for an audience of investors. The BioDiem presentation focused on BioDiem’s revenue-generating LAIV Vaccine program, and its antimicrobial BDM-I, which is being commercialised through BioDiem’s subsidiary, Opal Biosciences.

To view the presentation, please click here

Crowd Mobile Launches 5 New Apps

7th December 2915, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) is pleased to announce that it has launched five new lifestyle apps, further expanding and diversifying its apps business and leveraging its existing micro-job platform network.

The development of the new apps is consistent with Crowd Mobile’s organic growth strategy of increasing its content offering with entertaining and high engagement apps aimed at a broad demographic. The five new apps include:

  • Hillary – Q&A with French reality TV star Hillary Ch’tis (in French)
  • Thirsty – Cocktail Q&A app with thousands of recipes and instructions
  • Flawless – Make-up advice – Q&A app
  • Gossip Factory – Relationship & Celebrity Gossip – Q&A app
  • App Guru – Germany’s favorite Q&A App (in German)

To read the full announcement, please click here

BioDiem Entitlement Offer

Dear Shareholder,

You should have received by now

  • a copy of our current BioDiem Prospectus; and
  • a personalized entitlement and acceptance form, including BPay details.

***The closing date for the Offer is Monday, 14 December, 2015 (5pm).***

Should you not have received these or require replacements, please contact Rachel Kiely at our office on (03) 9692 7240.

The Prospectus is available on our website.

Should you wish any additional information, please contact Rachel on info@biodiem.com.

I will take this opportunity to wish our shareholders and their families the very best for Xmas and the New Year. Thank you for your ongoing support and please ensure we have your email address so we can keep you up-to-date on progress and events in BioDiem and Opal Biosciences.

Further Information

 

Martin Jetpack Signs Deals for China Ironman Clubs

6th December 2015, ASX Announcement

Martin Aircraft Company Limited (Martin Aircraft), (ASX:MJP) is pleased to announce that its Hong Kong based joint venture company, KuangChi Martin Jetpack Ltd (KCMJ), has signed 3 Intention Framework Agreements for a total of 100 manned Jetpacks and 20 simulators.

It is noted that at this stage the agreements are subject to agreeing procurement contracts by 30 June 2016 which will include final purchase price and support for each of the packages. Each package is part of the China “Ironman Club” concept where each Company provides Martin Jetpack and KuangChi Science capabilities in China.

The agreements were signed on 6 December 2015 at the first public flight demonstration of the P12 Martin Jetpack held at the Shenzhen OTC Waterpark in front of a crowd of 2,400 VIPs and distinguished guests along with members of the public. This marks another significant step forward for Martin Aircraft as it moves towards full commercialisation. The signing of the agreements follows a number of discussions led by both KuangChi Science Limited (HKSE: 00439) and the KuangChi Martin Jetpack Joint Venture in China.

Martin Aircraft Company chief executive Peter Coker said last week the P12 – flown by the firm’s director of flight operations, Mike Read, a former Australian Air Force pilot – would fly up to 8m above the OCT Waterpark, in the Southern Chinese city of Shenzhen, for about five minutes.

An unmanned version was also flown in Shenzhen. The jetpack can be flown by a pilot or remote control and potential uses include search and rescue, military, recreational, and commercial applications.

Martin Aircraft hopes to have the first deliveries of its commercial jetpack in the second half of next year and a personal jetpack available from the second quarter of 2017. It reported a $5.2 million full-year loss in August after raising $28 million in its Australian listing.

The jetpack is able to be flown by a pilot or via remote control and its potential use includes search and rescue, military, recreational, and commercial applications. It can fly for up to 30 minutes at a maximum speed of 74 kilometres an hour at an altitude of 1,000 metres.

To watch a video of the Martin Jetpack in action, please click here.

To read the ASX Announcement, please click here.

To read the New Zealand Herald article, please click here.

Crowd Mobile Trading Update and Investor Presentation

3rd December 2015, ASX Announcement

Crowd Mobile Limited (ASX:CM8 & FWB-XETRA:CM3) (“Crowd Mobile”) is pleased to provide an update on its operations for the month of November 2015, the first full month of trading following the completion of the Track Holdings B.V. (“Track”) acquisition.

Key highlights for November include: 

  • Revenue of AUD$4.0million (unaudited)
  • Earnings before interest, tax, depreciation and amortisation (EBITDA) of AUD$1.1million (unaudited)
  • Track integration progressing to plan
  • Appointment of Hans de Back as Chief Executive Officer of Track

To read the full announcement, please click here

To view the Investor Presentation, please click here.

iFAST Proposed Acquisition Of A Stockbroking Firm In Hong Kong

3rd December 2015, iFAST Corporation

The Board of Directors of iFAST Corporation Ltd. (“the Company”, or together with its subsidiaries, the “Group”) refers to the announcement released by the Company on 10 June 2015 relating to the Agreement for the Sale and Purchase of the entire share capital of Winfield Securities Limited (“Winfield Securities”) representing 10,000,000 shares of HK$1.00 each in the issued and paid-up share capital of Winfield Securities (“Proposed Acquisition”), subject to approval from the Securities and Futures Commission of Hong Kong (“SFC”).

The Company wishes to announce that the Company had received approval from SFC, subject to certain statutory conditions from SFC regarding the Proposed Acquisition of Winfield Securities.

The Company will provide updates on the completion as and when appropriate.

None of the Directors or substantial shareholders of the Company have any interest, directly or indirectly, in the said transaction save for their interest arising by way of their shareholdings and/or directorships, as the case may be, in the Company.

To read the full announcement, please click here

Folkestone Investor Update December 2015

Postcard from Asia

Australia is firmly on the map as the hotspot for investing into non-residential real estate in 2016.

APREA, the leading industry association for listed real estate in Asia, held their annual conference in Singapore last week. Some of the world’s largest and most savvy sovereign wealth funds, investment managers and Asian listed REITs were in attendance.

The clear message is that the wave of global capital flowing into Australia shows no sign of abating. Speaker after speaker, pointed to Australian non-residential real estate’s high yield relative to other markets, the wide spread between yields and the cost of debt, the weaker Australian dollar, and Australia’s transparent market as key reasons why they wanted to deploy capital in Australia.
Read more

Residential Monthly Performance

A summary of the latest investment performance for residential property according to the CoreLogic RP Data Home Value Index – November Update.
Read more

 Adrian Harrington Appointed Independent Director to AHURI Board

Mr Adrian Harrington has been appointed by the Federal Minister for Social Services, the Hon Christian Porter MP, as an Independent Director to the AHURI Board effective from 27 November 2015 for a term of 4 years. Adrian is currently Head of Funds Management at Folkestone.
Read more